Publications

Journals

• Colasanti A; Searle GE; Long CJ; Hill SP; Reiley RR; Quelch D; Erritzoe D; Tziortzi AC; et alReed LJ; Lingford-Hughes AR; Waldman AD; Schruers KR; Matthews PM; Gunn RN; Nutt DJ; Rabiner EA. (2 Mar 2012). Endogenous Opioid Release in the Human Brain Reward System Induced by Acute Amphetamine Administration. Biol Psychiatry. DOI.
• Newbould RD; Miller SR; Toms LD; Swann P; Tielbeek JA; Gold GE; Strachan RK; Taylor PC; et alMatthews PM; Brown AP. (7 Feb 2012). T2* measurement of the knee articular cartilage in osteoarthritis at 3T. J Magn Reson Imaging. DOI.
• Cole DM; Beckmann CF; Searle GE; Plisson C; Tziortzi AC; Nichols TE; Gunn RN; Matthews PM; et alRabiner EA; Beaver JD. (19 Dec 2011). Orbitofrontal Connectivity with Resting-State Networks Is Associated with Midbrain Dopamine D3 Receptor Availability. Cereb Cortex. DOI.
• Stagg CJ; Bachtiar V; O'Shea J; Allman C; Bosnell RA; Kischka U; Matthews PM; Johansen-Berg H. (Jan 2012). Cortical activation changes underlying stimulation-induced behavioural gains in chronic stroke. Brain. 135:276-284. DOI.
• Filippini N; Nickerson LD; Beckmann CF; Ebmeier KP; Frisoni GB; Matthews PM; Smith SM; Mackay CE. (15 Feb 2012). Age-related adaptations of brain function during a memory task are also present at rest. Neuroimage. 59:3821-3828. DOI.
• Gelineau-Morel R; Tomassini V; Jenkinson M; Johansen-Berg H; Matthews PM; Palace J. (5 Oct 2011). The effect of hypointense white matter lesions on automated gray matter segmentation in multiple sclerosis. Hum Brain Mapp. DOI.
• Owen DR; Matthews PM. (2011). Imaging brain microglial activation using positron emission tomography and translocator protein-specific radioligands. Int Rev Neurobiol. 101:19-39. DOI.
• De Silva A; Salem V; Long CJ; Makwana A; Newbould RD; Rabiner EA; Ghatei MA; Bloom SR; et alMatthews PM; Beaver JD; Dhillo WS. (2 Nov 2011). The gut hormones PYY 3-36 and GLP-1 7-36 amide reduce food intake and modulate brain activity in appetite centers in humans. Cell Metab. 14:700-706. DOI.
• Newbould RD; Miller SR; Tielbeek JA; Toms LD; Rao AW; Gold GE; Strachan RK; Taylor PC; et alMatthews PM; Brown AP. (Jan 2012). Reproducibility of sodium MRI measures of articular cartilage of the knee in osteoarthritis. Osteoarthritis Cartilage. 20:29-35. DOI.
• Owen DR; Yeo AJ; Gunn RN; Song K; Wadsworth G; Lewis A; Rhodes C; Pulford DJ; et alBennacef I; Parker CA; StJean PL; Cardon LR; Mooser VE; Matthews PM; Rabiner EA; Rubio JP. (Jan 2012). An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28. J Cereb Blood Flow Metab. 32:1-5. DOI.
• Roosendaal SD; Bendfeldt K; Vrenken H; Polman CH; Borgwardt S; Radue EW; Kappos L; Pelletier D; et alHauser SL; Matthews PM; Barkhof F; Geurts JJG. (1 Sep 2011). Grey matter volume in a large cohort of MS patients: relation to MRI parameters and disability. MULTIPLE SCLEROSIS JOURNAL. 17:1098-1106. Author weblink DOI.
• Bosnell RA; Kincses T; Stagg CJ; Tomassini V; Kischka U; Jbabdi S; Woolrich MW; Andersson J; et alMatthews PM; Johansen-Berg H. (1 Sep 2011). Motor Practice Promotes Increased Activity in Brain Regions Structurally Disconnected After Subcortical Stroke. NEUROREHABILITATION AND NEURAL REPAIR. 25:607-616. Author weblink DOI.
• Zarei M; Mataix-Cols D; Heyman I; Hough M; Doherty J; Burge L; Winmill L; Nijhawan S; et alMatthews PM; James A. (1 Dec 2011). Changes in gray matter volume and white matter microstructure in adolescents with obsessive-compulsive disorder. Biol Psychiatry. 70:1083-1090. DOI.
• Matthews PM; Rabiner EA; Passchier J; Gunn RN. (Feb 2012). Positron emission tomography molecular imaging for drug development. Br J Clin Pharmacol. 73:175-186. DOI.
• Bosnell RA; Kincses T; Stagg CJ; Tomassini V; Kischka U; Jbabdi S; Woolrich MW; Andersson J; et alMatthews PM; Johansen-Berg H. (Sep 2011). Motor practice promotes increased activity in brain regions structurally disconnected after subcortical stroke. Neurorehabil Neural Repair. 25:607-616. DOI.
• Rabiner EA; Beaver J; Makwana A; Searle G; Long C; Nathan PJ; Newbould RD; Howard J; et alMiller SR; Bush MA; Hill S; Reiley R; Passchier J; Gunn RN; Matthews PM; Bullmore ET. (Aug 2011). Molecular and functional neuroimaging of human opioid receptor pharmacology. Mol Psychiatry. 16:785. DOI.
• Thomas EL; Makwana A; Newbould R; Rao AW; Gambarota G; Frost G; Delafont B; Mishra RG; et alMatthews PM; Berk ES; Schwartz SM; Bell JD; Beaver JD. (Nov 2011). Pragmatic study of orlistat 60 mg on abdominal obesity. Eur J Clin Nutr. 65:1256-1262. DOI.
• Sombekke MH; Jafari N; Bendfeldt K; Mueller-Lenke N; Radue EW; Naegelin Y; Kappos L; Matthews PM; et alPolman CH; Barkhof F; Hintzen R; Geurts JJG. (1 May 2011). NO INFLUENCE OF KIF1B ON NEURODEGENERATIVE MARKERS IN MULTIPLE SCLEROSIS. NEUROLOGY. 76:1843-1845.
• Matthews PM; Rabiner I; Gunn R. (Oct 2011). Non-invasive imaging in experimental medicine for drug development. Curr Opin Pharmacol. 11:501-507. DOI.
• Beaver JD; Long CJ; Cole DM; Durcan MJ; Bannon LC; Mishra RG; Matthews PM. (Aug 2011). The effects of nicotine replacement on cognitive brain activity during smoking withdrawal studied with simultaneous fMRI/EEG. Neuropsychopharmacology. 36:1792-1800. DOI.
• Rabiner EA; Beaver J; Makwana A; Searle G; Long C; Nathan PJ; Newbould RD; Howard J; et alMiller SR; Bush MA; Hill S; Reiley R; Passchier J; Gunn RN; Matthews PM; Bullmore ET. (Aug 2011). Pharmacological differentiation of opioid receptor antagonists by molecular and functional imaging of target occupancy and food reward-related brain activation in humans. Mol Psychiatry. 16:826-785. DOI.
• Valsasina P; Rocca MA; Absinta M; Sormani MP; Mancini L; De Stefano N; Rovira A; Gass A; et alEnzinger C; Barkhof F; Wegner C; Matthews PM; Filippi M. (Apr 2011). A multicentre study of motor functional connectivity changes in patients with multiple sclerosis. Eur J Neurosci. 33:1256-1263. DOI.
• James A; Hough M; James S; Winmill L; Burge L; Nijhawan S; Matthews PM; Zarei M. (May 2011). Greater white and grey matter changes associated with early cannabis use in adolescent-onset schizophrenia (AOS). Schizophr Res. 128:91-97. DOI.
• Stagg CJ; Jayaram G; Pastor D; Kincses ZT; Matthews PM; Johansen-Berg H. (Apr 2011). Polarity and timing-dependent effects of transcranial direct current stimulation in explicit motor learning. Neuropsychologia. 49:800-804. DOI.
• James A; Hough M; James S; Burge L; Winmill L; Nijhawan S; Matthews PM; Zarei M. (Feb 2011). Structural brain and neuropsychometric changes associated with pediatric bipolar disorder with psychosis. Bipolar Disord. 13:16-27. DOI.
• Dixson L; Ridler K; Nichols TE; Saemann PG; Auer DP; Holsboer F; Muglia P; Matthews PM; et alInkster B. (Jul 2011). Thyroid hormone transporter genes and grey matter changes in patients with major depressive disorder and healthy controls. Psychoneuroendocrinology. 36:929-934. DOI.
• Owen DR; Piccini P; Matthews PM. (Mar 2011). Towards molecular imaging of multiple sclerosis. Mult Scler. 17:262-272. DOI.
• Douaud G; Jbabdi S; Behrens TE; Menke RA; Gass A; Monsch AU; Rao A; Whitcher B; et alKindlmann G; Matthews PM; Smith S. (1 Apr 2011). DTI measures in crossing-fibre areas: increased diffusion anisotropy reveals early white matter alteration in MCI and mild Alzheimer's disease. Neuroimage. 55:880-890. DOI.
• Owen DR; Gunn RN; Rabiner EA; Bennacef I; Fujita M; Kreisl WC; Innis RB; Pike VW; et alReynolds R; Matthews PM; Parker CA. (Jan 2011). Mixed-affinity binding in humans with 18-kDa translocator protein ligands. J Nucl Med. 52:24-32. DOI.
• Crofts JJ; Higham DJ; Bosnell R; Jbabdi S; Matthews PM; Behrens TEJ; Johansen-Berg H. (1 Jan 2011). Network analysis detects changes in the contralesional hemisphere following stroke. NEUROIMAGE. 54:161-169. DOI.
• Inkster B; Rao AW; Ridler K; Nichols TE; Saemann PG; Auer DP; Holsboer F; Tozzi F; et alMuglia P; Merlo-Pich E; Matthews PM. (Oct 2011). Structural brain changes in patients with recurrent major depressive disorder presenting with anxiety symptoms. J Neuroimaging. 21:375-382. DOI.
• Tzimopoulou S; Cunningham VJ; Nichols TE; Searle G; Bird NP; Mistry P; Dixon IJ; Hallett WA; et alWhitcher B; Brown AP; Zvartau-Hind M; Lotay N; Lai RY; Castiglia M; Jeter B; Matthews JC; Chen K; Bandy D; Reiman EM; Gold M; Rabiner EA; Matthews PM. (2010). A multi-center randomized proof-of-concept clinical trial applying [¹⁸F]FDG-PET for evaluation of metabolic therapy with rosiglitazone XR in mild to moderate Alzheimer's disease. J Alzheimers Dis. 22:1241-1256. DOI.
• Matthews PM. (1 Apr 2010). IMAGING FOR TRANSLATIONAL PHARMACOLOGY. IRISH JOURNAL OF MEDICAL SCIENCE. 179:S99-S100.
• Tomassini V; Johansen-Berg H; Leonardi L; Paixão L; Jbabdi S; Palace J; Pozzilli C; Matthews PM. (Jan 2011). Preservation of motor skill learning in patients with multiple sclerosis. Mult Scler. 17:103-115. DOI.
• Filippini N; Ebmeier KP; MacIntosh BJ; Trachtenberg AJ; Frisoni GB; Wilcock GK; Beckmann CF; Smith SM; et alMatthews PM; Mackay CE. (1 Jan 2011). Differential effects of the APOE genotype on brain function across the lifespan. Neuroimage. 54:602-610. DOI.
• Matthews PM; Wise RG. (1 Jul 2006). Noninvasive brain imaging for experimental medicine in drug discovery. EXPERT OPINION ON DRUG DISCOVERY. 1:111-121. DOI.
• Menke RA; Jbabdi S; Miller KL; Matthews PM; Zarei M. (4 Jun 2010). Connectivity-based segmentation of the substantia Nigra in human and its implications in Parkinson's disease. Neuroimage. DOI.
• Wise RG; Pattinson KT; Bulte DP; Rogers R; Tracey I; Matthews PM; Jezzard P. (Oct 2010). Measurement of relative cerebral blood volume using BOLD contrast and mild hypoxic hypoxia. Magn Reson Imaging. 28:1129-1134. DOI.
• Menke RA; Jbabdi S; Miller KL; Matthews PM; Zarei M. (1 Oct 2010). Connectivity-based segmentation of the substantia nigra in human and its implications in Parkinson's disease. Neuroimage. 52:1175-1180.
• Sloan HL; Austin VC; Blamire AM; Schnupp JW; Lowe AS; Allers KA; Matthews PM; Sibson NR. (1 Nov 2010). Regional differences in neurovascular coupling in rat brain as determined by fMRI and electrophysiology. Neuroimage. 53:399-411. DOI.
• Kasperaviciute D; Catarino CB; Heinzen EL; Depondt C; Cavalleri GL; Caboclo LO; Tate SK; Jamnadas-Khoda J; et alChinthapalli K; Clayton LMS; Shianna KV; Radtke RA; Mikati MA; Gallentine WB; Husain AM; Alhusaini S; Leppert D; Middleton LT; Gibson RA; Johnson MR; Matthews PM; Hosford D; Heuser K; Amos L; Ortega M; Zumsteg D; Wieser H-G; Steinhoff BJ; Kraermer G; Hansen J; Dorn T; Kantanen A-M; Gjerstad L; Peuralinna T; Hernandez DG; Eriksson KJ; Kalviainen RK; Doherty CP; Wood NW; Pandolfo M; Duncan JS; Sander JW; Delanty N; Goldstein DB; Sisodiya SM. (1 Jul 2010). Common genetic variation and susceptibility to partial epilepsies: a genome-wide association study. BRAIN. 133:2136-2147. DOI.
• Inkster B; Rao AW; Ridler K; Filippini N; Whitcher B; Nichols TE; Wetten S; Gibson RA; et alBorrie M; Kertesz A; Guzman DA; Loy-English I; Williams J; Saemann PG; Auer DP; Holsboer F; Tozzi F; Muglia P; Merlo-Pich E; Matthews PM. (Mar 2012). Genetic variation in GOLM1 and prefrontal cortical volume in Alzheimer's disease. Neurobiol Aging. 33:457-465. DOI.
• Heinzen EL; Radtke RA; Urban TJ; Cavalleri GL; Depondt C; Need AC; Walley NM; Nicoletti P; et alGe D; Catarino CB; Duncan JS; Kasperaviciute D; Tate SK; Caboclo LO; Sander JW; Clayton L; Linney KN; Shianna KV; Gumbs CE; Smith J; Cronin KD; Maia JM; Doherty CP; Pandolfo M; Leppert D; Middleton LT; Gibson RA; Johnson MR; Matthews PM; Hosford D; Kalviainen R; Eriksson K; Kantanen A-M; Dorn T; Hansen J; Kraemer G; Steinhoff BJ; Wieser H-G; Zumsteg D; Ortega M; Wood NW; Huxley-Jones J; Mikati M; Gallentine WB; Husain AM; Buckley PG; Stallings RL; Podgoreanu MV; Delanty N; Sisodiya SM; Goldstein DB. (14 May 2010). Rare Deletions at 16p13.11 Predispose to a Diverse Spectrum of Sporadic Epilepsy Syndromes. AMERICAN JOURNAL OF HUMAN GENETICS. 86:707-718. Author weblink DOI.
• Tomassini V; Jbabdi S; Kincses ZT; Bosnell R; Douaud G; Pozzilli C; Matthews PM; Johansen-Berg H. (Mar 2011). Structural and functional bases for individual differences in motor learning. Hum Brain Mapp. 32:494-508. DOI.
• Pomeroy IM; Jordan EK; Frank JA; Matthews PM; Esiri MM. (May 2010). Focal and diffuse cortical degenerative changes in a marmoset model of multiple sclerosis. Mult Scler. 16:537-548. DOI.
• Zarei M; Patenaude B; Damoiseaux J; Morgese C; Smith S; Matthews PM; Barkhof F; Rombouts SARB; et alSanz-Arigita E; Jenkinson M. (1 Jun 2010). Combining shape and connectivity analysis: An MRI study of thalamic degeneration in Alzheimer's disease (vol 49, pg 1, 2010). NEUROIMAGE. 51:940-940. Author weblink DOI.
• Owen DR; Howell OW; Tang SP; Wells LA; Bennacef I; Bergstrom M; Gunn RN; Rabiner EA; et alWilkins MR; Reynolds R; Matthews PM; Parker CA. (Sep 2010). Two binding sites for [3H]PBR28 in human brain: implications for TSPO PET imaging of neuroinflammation. J Cereb Blood Flow Metab. 30:1608-1618. DOI.
• Cole DM; Beckmann CF; Long CJ; Matthews PM; Durcan MJ; Beaver JD. (15 Aug 2010). Nicotine replacement in abstinent smokers improves cognitive withdrawal symptoms with modulation of resting brain network dynamics. Neuroimage. 52:590-599. DOI.
• Inkster B; Nichols TE; Saemann PG; Auer DP; Holsboer F; Muglia P; Matthews PM. (15 Nov 2010). Pathway-based approaches to imaging genetics association studies: Wnt signaling, GSK3beta substrates and major depression. Neuroimage. 53:908-917. DOI.
• Matthews PM; Comley R. (1 Nov 2009). Advances in the molecular imaging of multiple sclerosis. EXPERT REVIEW OF CLINICAL IMMUNOLOGY. 5:765-777. Author weblink DOI.
• Voets NL; Adcock JE; Stacey R; Hart Y; Carpenter K; Matthews PM; Beckmann CF. (1 Dec 2009). Functional and Structural Changes in the Memory Network Associated with Left Temporal Lobe Epilepsy. HUMAN BRAIN MAPPING. 30:4070-4081. Author weblink DOI.
• Giorgio A; Watkins KE; Chadwick M; James S; Winmill L; Douaud G; De Stefano N; Matthews PM; et alSmith SM; Johansen-Berg H; James AC. (1 Jan 2010). Longitudinal changes in grey and white matter during adolescence. NEUROIMAGE. 49:94-103. Author weblink DOI.
• Zarei M; Patenaude B; Damoiseaux J; Morgese C; Smith S; Matthews PM; Barkhof F; Rombouts S; et alSanz-Arigita E; Jenkinson M. (1 Jan 2010). Combining shape and connectivity analysis: An MRI study of thalamic degeneration in Alzheimer's disease. NEUROIMAGE. 49:1-8. Author weblink DOI.
• David SP; Munafo MR; Johansen-Berg H; MacKillop J; Sweet LH; Cohen RA; Niaura R; Rogers RD; et alMatthews PM; Walton RT. (1 Dec 2007). Effects of Acute Nicotine Abstinence on Cue-elicited Ventral Striatum/Nucleus Accumbens Activation in Female Cigarette Smokers: A Functional Magnetic Resonance Imaging Study. BRAIN IMAGING AND BEHAVIOR. 1:43-57. Author weblink DOI.
• Stagg CJ; O'Shea J; Kincses ZT; Woolrich M; Matthews PM; Johansen-Berg H. (Oct 2009). Modulation of movement-associated cortical activation by transcranial direct current stimulation. Eur J Neurosci. 30:1412-1423. DOI.
• Rocca MA; Absinta M; Valsasina P; Ciccarelli O; Marino S; Rovira A; Gass A; Wegner C; et alEnzinger C; Korteweg T; Sormani MP; Mancini L; Thompson AJ; De Stefano N; Montalban X; Hirsch J; Kappos L; Ropele S; Palace J; Barkhof F; Matthews PM; Filippi M. (1 Aug 2009). Abnormal Connectivity of the Sensorimotor Network in Patients With MS: A MultiCenter fMRI Study. HUMAN BRAIN MAPPING. 30:2412-2425. Author weblink DOI.
• Stefansson H; Ophoff RA; Steinberg S; Andreassen OA; Cichon S; Rujescu D; Werge T; Pietilainen OPH; et alMors O; Mortensen PB; Sigurdsson E; Gustafsson O; Nyegaard M; Tuulio-Henriksson A; Ingason A; Hansen T; Suvisaari J; Lonnqvist J; Paunio T; Borglum AD; Hartmann A; Fink-Jensen A; Nordentoft M; Hougaard D; Norgaard-Pedersen B; Bottcher Y; Olesen J; Breuer R; Moeller H-J; Giegling I; Rasmussen HB; Timm S; Mattheisen M; Bitter I; Rethelyi JM; Magnusdottir BB; Sigmundsson T; Olason P; Mason G; Gulcher JR; Haraldsson M; Fossdal R; Thorgeirsson TE; Thorsteinsdottir U; Ruggeri M; Tosato S; Franke B; Strengman E; Kiemeney LA; Melle I; Djurovic S; Abramova L; Kaleda V; Sanjuan J; de Frutos R; Bramon E; Vassos E; Fraser G; Ettinger U; Picchioni M; Walker N; Toulopoulou T; Need AC; Ge D; Yoon JL; Shianna KV; Freimer NB; Cantor RM; Murray R; Kong A; Golimbet V; Carracedo A; Arango C; Costas J; Joensson EG; Terenius L; Agartz I; Petursson H; Nothen MM; Rietschel M; Matthews PM; Muglia P; Peltonen L; St Clair D; Goldstein DB; Stefansson K; Collier DA. (6 Aug 2009). Common variants conferring risk of schizophrenia. NATURE. 460:744-U99. Author weblink DOI.
• Cader S; Palace J; Matthews PM. (1 Aug 2009). Cholinergic agonism alters cognitive processing and enhances brain functional connectivity in patients with multiple sclerosis. JOURNAL OF PSYCHOPHARMACOLOGY. 23:686-696. Author weblink DOI.
• De Jager PL; Jia X; Wang J; de Bakker PIW; Ottoboni L; Aggarwal NT; Piccio L; Raychaudhuri S; et alTran D; Aubin C; Briskin R; Romano S; Baranzini SE; McCauley JL; Pericak-Vance MA; Haines JL; Gibson RA; Naeglin Y; Uitdehaag B; Matthews PM; Kappos L; Polman C; McArdle WL; Strachan DP; Evans D; Cross AH; Daly MJ; Compston A; Sawcer SJ; Weiner HL; Hauser SL; Hafler DA; Oksenberg JR. (1 Jul 2009). Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. NATURE GENETICS. 41:776-U26. Author weblink DOI.
• Menke RA; Scholz J; Miller KL; Deoni S; Jbabdi S; Matthews PM; Zarei M. (15 Aug 2009). MRI characteristics of the substantia nigra in Parkinson's disease: A combined quantitative T1 and DTI study. NEUROIMAGE. 47:435-441. Author weblink DOI.
• Enzinger C; Dawes H; Johansen-Berg H; Wade D; Bogdanovic M; Collett J; Guy C; Kischka U; et alRopele S; Fazekas F; Matthews PM. (1 Jul 2009). Brain Activity Changes Associated With Treadmill Training After Stroke. STROKE. 40:2460-2467. Author weblink DOI.
• Inkster B; Nichols TE; Saemann PG; Auer DP; Holsboer F; Muglia P; Matthews PM. (Jul 2009). Association of GSK3beta polymorphisms with brain structural changes in major depressive disorder. Arch Gen Psychiatry. 66:721-728. DOI.
• Stagg CJ; Wylezinska M; Matthews PM; Johansen-Berg H; Jezzard P; Rothwell JC; Bestmann S. (1 Jun 2009). Neurochemical Effects of Theta Burst Stimulation as Assessed by Magnetic Resonance Spectroscopy. JOURNAL OF NEUROPHYSIOLOGY. 101:2872-2877. Author weblink DOI.
• Douaud G; Mackay C; Andersson J; James S; Quested D; Ray MK; Connell J; Roberts N; et alCrow TJ; Matthews PM; Smith S; James A. (Sep 2009). Schizophrenia delays and alters maturation of the brain in adolescence. Brain. 132:2437-2448. DOI.
• Filippini N; MacIntosh BJ; Hough MG; Goodwin GM; Frisoni GB; Smith SM; Matthews PM; Beckmann CF; et alMackay CE. (28 Apr 2009). Distinct patterns of brain activity in young carriers of the APOE-epsilon4 allele. Proc Natl Acad Sci U S A. 106:7209-7214. DOI.
• Stagg CJ; Best JG; Stephenson MC; O'Shea J; Wylezinska M; Kincses ZT; Morris PG; Matthews PM; et alJohansen-Berg H. (22 Apr 2009). Polarity-sensitive modulation of cortical neurotransmitters by transcranial stimulation. J Neurosci. 29:5202-5206. DOI.
• Mancini L; Ciccarelli O; Manfredonia F; Thornton JS; Agosta F; Barkhof F; Beckmann C; De Stefano N; et alEnzinger C; Fazekas F; Filippi M; Gass A; Hirsch JG; Johansen-Berg H; Kappos L; Korteweg T; Manson SC; Marino S; Matthews PM; Montalban X; Palace J; Polman C; Rocca M; Ropele S; Rovira A; Wegner C; Friston K; Thompson A; Yousry T. (1 Apr 2009). Short-term adaptation to a simple motor task: A physiological process preserved in multiple sclerosis. NEUROIMAGE. 45:500-511. Author weblink DOI.
• Bendfeldt K; Kuster P; Traud S; Egger H; Winklhofer S; Mueller-Lenke N; Naegelin Y; Gass A; et alKappos L; Matthews PM; Nichols TE; Radue E-W; Borgwardt SJ. (1 Mar 2009). Association of regional gray matter volume loss and progression of white matter lesions in multiple sclerosis - A longitudinal voxel-based morphometry study. NEUROIMAGE. 45:60-67. Author weblink DOI.
• Tamas KZ; Johansen-Berg H; Tomassini V; Bosnell R; Matthews PM; Beckmann CF. (30 Jan 2009). THE BRAIN INVOLVED IN MOTOR SEQUENCE LEARNING NETWORKS IDENTIFICATION MODEL WITH FMR-DATA ANALYSIS Peter Mihaly. IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE. 62:66-67. Author weblink.
• Ciccarelli O; Behrens TE; Johansen-Berg H; Talbot K; Orrell RW; Howard RS; Nunes RG; Miller DH; et alMatthews PM; Thompson AJ; Smith SM. (1 Feb 2009). Investigation of White Matter Pathology in ALS and PLS Using Tract-Based Spatial Statistics. HUMAN BRAIN MAPPING. 30:615-624. Author weblink DOI.
• Baranzini SE; Wang J; Gibson RA; Galwey N; Naegelin Y; Barkhof F; Radue E-W; Lindberg RLP; et alUitdehaag BMG; Johnson MR; Angelakopoulou A; Hall L; Richardson JC; Prinjha RK; Gass A; Geurts JJG; Kragt J; Sombekke M; Vrenken H; Qualley P; Lincoln RR; Gomez R; Caillier SJ; George MF; Mousavi H; Guerrero R; Okuda DT; Cree BAC; Green AJ; Waubant E; Goodin DS; Pelletier D; Matthews PM; Hauser SL; Kappos L; Polman CH; Oksenberg JR. (15 Feb 2009). Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. HUMAN MOLECULAR GENETICS. 18:767-778. Author weblink DOI.
• Filippini N; Rao A; Wetten S; Gibson RA; Borrie M; Guzman D; Kertesz A; Loy-English I; et alWilliams J; Nichols T; Whitcher B; Matthews PM. (1 Feb 2009). Anatomically-distinct genetic associations of APOE epsilon 4 allele load with regional cortical atrophy in Alzheimer's disease. NEUROIMAGE. 44:724-728. Author weblink DOI.
• Matthews PM. (1 Feb 2009). Brain Imaging of Multiple Sclerosis: the Next 10 Years. NEUROIMAGING CLINICS OF NORTH AMERICA. 19:101-+. Author weblink DOI.
• Zarei M; Damoiseaux JS; Morgese C; Beckmann CF; Smith SM; Matthews PM; Scheltens P; Rombouts SA; et alBarkhof F. (Mar 2009). Regional white matter integrity differentiates between vascular dementia and Alzheimer disease. Stroke. 40:773-779. DOI.
• Matthews PM. (1 Oct 2008). Approaching a renaissance in coma research responsibly. NATURE CLINICAL PRACTICE NEUROLOGY. 4:523-523. Author weblink DOI.
• Bhagwagar Z; Wylezinska M; Jezzard P; Evans J; Boorman E; Matthews PM; Cowen PJ. (1 Mar 2008). Low GABA concentrations in occipital cortex and anterior cingulate cortex in medication-free, recovered depressed patients. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 11:255-260. Author weblink DOI.
• Stefansson H; Rujescu D; Cichon S; Pietilainen OPH; Ingason A; Steinberg S; Fossdal R; Sigurdsson E; et alSigmundsson T; Buizer-Voskamp JE; Hansen T; Jakobsen KD; Muglia P; Francks C; Matthews PM; Gylfason A; Halldorsson BV; Gudbjartsson D; Thorgeirsson TE; Sigurdsson A; Jonasdottir A; Jonasdottir A; Bjornsson A; Mattiasdottir S; Blondal T; Haraldsson M; Magnusdottir BB; Giegling I; Moeller H-J; Hartmann A; Shianna KV; Ge D; Need AC; Crombie C; Fraser G; Walker N; Lonnqvist J; Suvisaari J; Tuulio-Henriksson A; Paunio T; Toulopoulou T; Bramon E; Di Forti M; Murray R; Ruggeri M; Vassos E; Tosato S; Walshe M; Li T; Vasilescu C; Muehleisen TW; Wang AG; Ullum H; Djurovic S; Melle I; Olesen J; Kiemeney LA; Franke B; Sabatti C; Freimer NB; Gulcher JR; Thorsteinsdottir U; Kong A; Andreassen OA; Ophoff RA; Georgi A; Rietschel M; Werge T; Petursson H; Goldstein DB; Noethen MM; Peltonen L; Collier DA; St Clair D; Stefansson K. (11 Sep 2008). Large recurrent microdeletions associated with schizophrenia. NATURE. 455:232-U61. Author weblink DOI.
• Voets NL; Hough MG; Douaud G; Matthews PM; James A; Winmill L; Webster P; Smith S. (Dec 2008). Evidence for abnormalities of cortical development in adolescent-onset schizophrenia. Neuroimage. 43:665-675. DOI.
• Bosnell R; Wegner C; Kincses ZT; Korteweg T; Agosta F; Ciccarelli O; De Stefano N; Gass A; et alHirsch J; Johansen-Berg H; Kappos L; Barkhof F; Mancini L; Manfredonia F; Marino S; Miller DH; Montalban X; Palace J; Rocca M; Enzinger C; Ropele S; Rovira A; Smith S; Thompson A; Thornton J; Yousry T; Whitcher B; Filippi M; Matthews PM. (15 Aug 2008). Reproducibility of fMRI in the clinical setting: Implications for trial designs. NEUROIMAGE. 42:603-610. Author weblink DOI.
• Matthews PM; Radda GK; Johansen-Berg H; Tracey I; Cowey A. (15 Sep 2008). Remembering John Newsom-Davis' contribution to human imaging in Oxford. J Neuroimmunol. 201-202:250-254. DOI.
• Ishihara-Paul L; Hulihan MM; Kachergus J; Upmanyu R; Warren L; Amouri R; Elango R; Prinjha RK; et alSoto A; Kefi M; Zouari M; Sassi SB; Yahmed SB; El Euch-Fayeche G; Matthews PM; Middleton LT; Gibson RA; Hentati F; Farrer MJ. (16 Sep 2008). PINK1 mutations and parkinsonism. Neurology. 71:896-902. DOI.
• Hulihan MM; Ishihara-Paul L; Kochergus J; Warren L; Amouri R; Elango R; Prinjha RK; Upmanyu R; et alKefi M; Zouari M; Ben Sassi S; Ben Yahmed S; El Euch-Fayeche G; Matthews PM; Middleton LT; Gibson RA; Hentati F; Farrer MJ. (1 Jul 2008). LRRK2 Gly2019Ser penetrance in Arab-Berber patients from Tunisia: a case-control genetic study. LANCET NEUROLOGY. 7:591-594. Author weblink DOI.
• Johansen-Berg H; Gutman DA; Behrens TE; Matthews PM; Rushworth MF; Katz E; Lozano AM; Mayberg HS. (Jun 2008). Anatomical connectivity of the subgenual cingulate region targeted with deep brain stimulation for treatment-resistant depression. Cereb Cortex. 18:1374-1383. DOI.
• Pomeroy IM; Jordan EK; Frank JA; Matthews PM; Esiri MM. (30 May 2008). Diffuse cortical atrophy in a marmoset model of multiple sclerosis. NEUROSCIENCE LETTERS. 437:121-124. Author weblink DOI.
• Enzinger C; Johansen-Berg H; Dawes H; Bogdanovic M; Collett J; Guy C; Ropele S; Kischka U; et alWade D; Fazekas F; Matthews PM. (May 2008). Functional MRI correlates of lower limb function in stroke victims with gait impairment. Stroke. 39:1507-1513. DOI.
• Manson SC; Wegner C; Filippi M; Barkhof F; Beckmann C; Ciccarelli O; De Stefano N; Enzinger C; et alFazekas F; Agosta F; Gass A; Hirsch J; Johansen-Berg H; Kappos L; Korteweg T; Polman C; Mancini L; Manfredonia F; Marino S; Miller DH; Montalban X; Palace J; Rocca M; Ropele S; Rovira A; Smith S; Thompson A; Thornton J; Yousry T; Frank JA; Matthews PM. (1 May 2008). Impairment of movement-associated brain deactivation in multiple sclerosis: further evidence for a functional pathology of interhemispheric neuronal inhibition. EXPERIMENTAL BRAIN RESEARCH. 187:25-31. Author weblink DOI.
• Allen HA; Humphreys GW; Matthews PM. (1 Apr 2008). A neural marker of content-specific active ignoring. JOURNAL OF EXPERIMENTAL PSYCHOLOGY-HUMAN PERCEPTION AND PERFORMANCE. 34:286-297. Author weblink DOI.
• Dawes H; Enzinger C; Johansen-Berg H; Bogdanovic M; Guy C; Collett J; Izadi H; Stagg C; et alWade D; Matthews PM. (Mar 2008). Walking performance and its recovery in chronic stroke in relation to extent of lesion overlap with the descending motor tract. Exp Brain Res. 186:325-333. DOI.
• Kineses ZT; Johansen-Berg H; Tomassini V; Bosnell R; Matthews PM; Beckmann CF. (15 Feb 2008). Model-free characterization of brain functional networks for motor sequence learning using fMRI. NEUROIMAGE. 39:1950-1958. Author weblink DOI.
• Wegner C; Filippi M; Korteweg T; Beckmann C; Ciccarelli O; De Stefano N; Enzinger C; Fazekas F; et alAgosta F; Gass A; Hirsch J; Johansen-Berg H; Kappos L; Barkhof F; Polman C; Mancini L; Manfredonia F; Marino S; Miller DH; Montalban X; Palace J; Rocca M; Ropele S; Rovira A; Smith S; Thompson A; Thornton J; Yousry T; Matthews PM. (1 Feb 2008). Relating functional changes during hand movement to clinical parameters in patients with multiple sclerosis in a multi-centre fMRI study. EUROPEAN JOURNAL OF NEUROLOGY. 15:113-122. Author weblink DOI.
• Li H; Wetten S; Li L; St Jean PL; Upmanyu R; Surh L; Hosford D; Barnes MR; et alBriley JD; Borrie M; Coletta N; Delisle R; Dhalla D; Ehm MG; Feldman HH; Fornazzari L; Gauthier S; Goodgame N; Guzman D; Hammond S; Hollingworth P; Hsiung GY; Johnson J; Kelly DD; Keren R; Kertesz A; King KS; Lovestone S; Loy-English I; Matthews PM; Owen MJ; Plumpton M; Pryse-Phillips W; Prinjha RK; Richardson JC; Saunders A; Slater AJ; St George-Hyslop PH; Stinnett SW; Swartz JE; Taylor RL; Wherrett J; Williams J; Yarnall DP; Gibson RA; Irizarry MC; Middleton LT; Roses AD. (Jan 2008). Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. Arch Neurol. 65:45-53. DOI.
• Giorgio A; Watkins KE; Douaud G; James AC; James S; De Stefano N; Matthews PM; Smith SM; et alJohansen-Berg H. (1 Jan 2008). Changes in white matter microstructure during adolescence. NEUROIMAGE. 39:52-61. Author weblink DOI.
• De Stefano N; Filippi M; Miller D; Pouwels PJ; Rovira A; Gass A; Enzinger C; Matthews PM; et alArnold DL. (13 Nov 2007). Guidelines for using proton MR spectroscopy in multicenter clinical MS studies. NEUROLOGY. 69:1942-1952. Author weblink DOI.
• Blamire AM; Cader S; Lee M; Palace J; Matthews PM. (1 Nov 2007). Axonal damage in the spinal cord of multiple sclerosis patients detected by magnetic resonance spectroscopy. MAGNETIC RESONANCE IN MEDICINE. 58:880-885. Author weblink DOI.
• Tomassini V; Jbabdi S; Klein JC; Behrens TE; Pozzilli C; Matthews PM; Rushworth MF; Johansen-Berg H. (19 Sep 2007). Diffusion-weighted imaging tractography-based parcellation of the human lateral premotor cortex identifies dorsal and ventral subregions with anatomical and functional specializations. J Neurosci. 27:10259-10269. DOI.
• Douaud G; Smith S; Jenkinson M; Behrens T; Johansen-Berg H; Vickers J; James S; Voets N; et alWatkins K; Matthews PM; James A. (1 Sep 2007). Anatomically related grey and white matter abnormalities in adolescent-onset schizophrenia. BRAIN. 130:2375-2386. Author weblink DOI.
• Smith SM; Rao A; De Stefano N; Jenkinson M; Schott JM; Matthews PM; Fox NC. (15 Jul 2007). Longitudinal and cross-sectional analysis of atrophy in Alzheimer's disease: Cross-validation of BSI, SIENA and SIENAX. NEUROIMAGE. 36:1200-1206. Author weblink DOI.
• Matthews PM. (Jul 2007). Molecular imaging of brain amyloid in mild cognitive impairment and Alzheimer's disease. Nat Clin Pract Neurol. 3:366-367. DOI.
• Cader S; Johansen-Berg H; Wylezinska M; Palace J; Behrens TE; Smith S; Matthews PM. (15 May 2007). Discordant white matter N-acetylasparate and diffusion MRI measures suggest that chronic metabolic dysfunction contributes to axonal pathology in multiple sclerosis. Neuroimage. 36:19-27. DOI.
• Bhagwagar Z; Wylezinska M; Jezzard P; Evans J; Ashworth F; Sule A; Matthews PM; Cowen PJ. (15 Mar 2007). Reduction in occipital cortex gamma-aminobutyric acid concentrations in medication-free recovered unipolar depressed and bipolar subjects. Biol Psychiatry. 61:806-812. DOI.
• Morgan RM; Parry AM; Arida RM; Matthews PM; Davies B; Castell LM. (Feb 2007). Effects of elevated plasma tryptophan on brain activation associated with the Stroop task. Psychopharmacology (Berl). 190:383-389. DOI.
• Matthews PM; Talbot K. (Feb 2007). Magnetic resonance spectroscopic imaging--of prognostic value in amyotrophic lateral sclerosis?. Nat Clin Pract Neurol. 3:76-77. DOI.
• Zarei M; Johansen-Berg H; Jenkinson M; Ciccarelli O; Thompson AJ; Matthews PM. (Jan 2007). Two-dimensional population map of cortical connections in the human internal capsule. J Magn Reson Imaging. 25:48-54. DOI.
• Schloesser RGM; Nenadic I; Wagner G; Guellmar D; von Consbruch K; Koehler S; Schultz CC; Koch K; et alFitzek C; Matthews PM; Reichenbach JR; Sauer H. (1 Jan 2007). White matter abnormalities and brain activation in schizophrenia: A combined DTI and fMRI study. SCHIZOPHRENIA RESEARCH. 89:1-11. Author weblink DOI.
• Abu-Omar Y; Cader S; Guerrieri Wolf L; Pigott D; Matthews PM; Taggart DP. (Nov 2006). Short-term changes in cerebral activity in on-pump and off-pump cardiac surgery defined by functional magnetic resonance imaging and their relationship to microembolization. J Thorac Cardiovasc Surg. 132:1119-1125. DOI.
• Manson SC; Palace J; Frank JA; Matthews PM. (Oct 2006). Loss of interhemispheric inhibition in patients with multiple sclerosis is related to corpus callosum atrophy. Exp Brain Res. 174:728-733. DOI.
• Wegner C; Esiri MM; Chance SA; Palace J; Matthews PM. (26 Sep 2006). Neocortical neuronal, synaptic, and glial loss in multiple sclerosis. Neurology. 67:960-967. DOI.
• Matthews PM; Honey GD; Bullmore ET. (Sep 2006). Applications of fMRI in translational medicine and clinical practice. Nat Rev Neurosci. 7:732-744. DOI.
• Farrugia ME; Robson MD; Kennett RP; Matthews PM; Anslow P; Hilton-Jones D; Newsom-Davis J; Vincent A. (1 Sep 2006). Facial muscle atrophy in musk antibody positive myasthenia gravis. EUROPEAN JOURNAL OF NEUROLOGY. 13:23-23. Author weblink.
• Zarei M; Johansen-Berg H; Smith S; Ciccarelli O; Thompson AJ; Matthews PM. (Sep 2006). Functional anatomy of interhemispheric cortical connections in the human brain. J Anat. 209:311-320. DOI.
• Jamison HL; Watkins KE; Bishop DV; Matthews PM. (Sep 2006). Hemispheric specialization for processing auditory nonspeech stimuli. Cereb Cortex. 16:1266-1275. DOI.
• Enzinger C; Smith S; Fazekas F; Drevin G; Ropele S; Nichols T; Behrens T; Schmidt R; et alMatthews PM. (1 Aug 2006). Lesion probability maps of white matter hyperintensities in elderly individuals - Results of the Austrian stroke prevention study. JOURNAL OF NEUROLOGY. 253:1064-1070. Author weblink DOI.
• Smith SM; Jenkinson M; Johansen-Berg H; Rueckert D; Nichols TE; Mackay CE; Watkins KE; Ciccarelli O; et alCader MZ; Matthews PM; Behrens TE. (15 Jul 2006). Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage. 31:1487-1505. DOI.
• Ciccarelli O; Toosy AT; Marsden JE; Wheeler-Kingshott CM; Miller DH; Matthews PM; Thompson AJ. (1 Jul 2006). Functional response to active and passive ankle movements with clinical correlations in patients with primary progressive multiple sclerosis. JOURNAL OF NEUROLOGY. 253:882-891. Author weblink DOI.
• Ciccarelli O; Behrens TE; Altmann DR; Orrell RW; Howard RS; Johansen-Berg H; Miller DH; Matthews PM; et alThompson AJ. (1 Jul 2006). Probabilistic diffusion tractography: a potential tool to assess the rate of disease progression in amyotrophic lateral sclerosis. BRAIN. 129:1859-1871. Author weblink DOI.
• Farrugia ME; Robson MD; Clover L; Anslow P; Newsom-Davis J; Kennett R; Hilton-Jones D; Matthews PM; et alVincent A. (Jun 2006). MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis. Brain. 129:1481-1492. DOI.
• Ramnani N; Behrens TEJ; Johansen-Berg H; Richter MC; Pinsk MA; Andersson JLR; Rudebeck P; Ciccarelli O; et alRichter W; Thompson AJ; Gross CG; Robson MD; Kastner S; Matthews PM. (1 Jun 2006). The evolution of prefrontal inputs to the cortico-pontine system: Diffusion imaging evidence from macaque monkeys and humans. CEREBRAL CORTEX. 16:811-818. Author weblink DOI.
• Devlin JT; Jamison HL; Gonnerman LM; Matthews PM. (Jun 2006). The role of the posterior fusiform gyrus in reading. J Cogn Neurosci. 18:911-922. DOI.
• Selvaraj S; Wylezinska M; Evans J; Jezzard P; Matthews PM; Cowen PJ. (3 May 2006). Tryptophan depletion does not lower brain GABA levels in healthy volunteers. Psychopharmacology (Berl). Publisher weblink DOI.
• Devlin JT; Sillery EL; Hall DA; Hobden P; Behrens TE; Nunes RG; Clare S; Matthews PM; et alMoore DR; Johansen-Berg H. (1 May 2006). Reliable identification of the auditory thalamus using multi-modal structural analyses. Neuroimage. 30:1112-1120. DOI.
• Mottonen R; Calvert GA; Jaaskelainen IP; Matthews PM; Thesen T; Tuomainen J; Sams M. (1 Apr 2006). Perceiving identical sounds as speech or non-speech modulates activity in the left posterior superior temporal sulcus. NEUROIMAGE. 30:563-569. Author weblink DOI.
• Voets NL; Adcock JE; Flitney DE; Behrens TE; Hart Y; Stacey R; Carpenter K; Matthews PM. (Mar 2006). Distinct right frontal lobe activation in language processing following left hemisphere injury. Brain. 129:754-766. DOI.
• Floyer-Lea A; Wylezinska M; Kincses T; Matthews PM. (Mar 2006). Rapid modulation of GABA concentration in human sensorimotor cortex during motor learning. J Neurophysiol. 95:1639-1644. DOI.
• De Luca M; Beckmann CF; De Stefano N; Matthews PM; Smith SM. (15 Feb 2006). fMRI resting state networks define distinct modes of long-distance interactions in the human brain. Neuroimage. 29:1359-1367. DOI.
• Cader S; Cifelli A; Abu-Omar Y; Palace J; Matthews PM. (Feb 2006). Reduced brain functional reserve and altered functional connectivity in patients with multiple sclerosis. Brain. 129:527-537. DOI.
• De Luca M; Smith S; De Stefano N; Federico A; Matthews PM. (Dec 2005). Blood oxygenation level dependent contrast resting state networks are relevant to functional activity in the neocortical sensorimotor system. Exp Brain Res. 167:587-594. DOI.
• Basoah A; Matthews PM; Morten KJ. (21 Nov 2005). Rapid rates of newly synthesized mitochondrial protein degradation are significantly affected by the generation of mitochondrial free radicals. FEBS Lett. 579:6511-6517. DOI.
• Iannetti GD; Niazy RK; Wise RG; Jezzard P; Brooks JC; Zambreanu L; Vennart W; Matthews PM; et alTracey I. (15 Nov 2005). Simultaneous recording of laser-evoked brain potentials and continuous, high-field functional magnetic resonance imaging in humans. Neuroimage. 28:708-719. DOI.
• Pomeroy IM; Matthews PM; Frank JA; Jordan EK; Esiri MM. (Nov 2005). Demyelinated neocortical lesions in marmoset autoimmune encephalomyelitis mimic those in multiple sclerosis. Brain. 128:2713-2721. DOI.
• Schmidt R; Ropele S; Enzinger C; Petrovic K; Smith S; Schmidt H; Matthews PM; Fazekas F. (1 Oct 2005). White matter lesion progression, brain atrophy, and cognitive decline: The Austrian Stroke Prevention Study. ANNALS OF NEUROLOGY. 58:610-616. Author weblink DOI.
• David SP; Munafò MR; Johansen-Berg H; Smith SM; Rogers RD; Matthews PM; Walton RT. (15 Sep 2005). Ventral striatum/nucleus accumbens activation to smoking-related pictorial cues in smokers and nonsmokers: a functional magnetic resonance imaging study. Biol Psychiatry. 58:488-494. DOI.
• Ciccarelli O; Toosy AT; Marsden JF; Wheeler-Kingshott CM; Sahyoun C; Matthews PM; Miller DH; Thompson AJ. (1 Sep 2005). Identifying brain regions for integrative sensorimotor processing with ankle movements. EXPERIMENTAL BRAIN RESEARCH. 166:31-42. Author weblink DOI.
• Tjandra T; Brooks JC; Figueiredo P; Wise R; Matthews PM; Tracey I. (15 Aug 2005). Quantitative assessment of the reproducibility of functional activation measured with BOLD and MR perfusion imaging: implications for clinical trial design. Neuroimage. 27:393-401. DOI.
• Matthews PM. (1 Aug 2005). Brain plasticity and clinical applications of fMRI. RIVISTA DI NEURORADIOLOGIA. 18:493-501. Author weblink.
• Floyer-Lea A; Matthews PM. (Jul 2005). Distinguishable brain activation networks for short- and long-term motor skill learning. J Neurophysiol. 94:512-518. DOI.
• Osterbauer RA; Matthews PM; Jenkinson M; Beckmann CF; Hansen PC; Calvert GA. (Jun 2005). Color of scents: chromatic stimuli modulate odor responses in the human brain. J Neurophysiol. 93:3434-3441. DOI.
• Abu-Omar Y; Matthews PM; Taggart DP. (1 May 2005). Distinguishing solid from gaseous emboli during cardiac surgery - Reply. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY. 129:1194-1195. Author weblink DOI.
• Smith SM; Beckmann CF; Ramnani N; Woolrich MW; Bannister PR; Jenkinson M; Matthews PM; McGonigle DJ. (Mar 2005). Variability in fMRI: a re-examination of inter-session differences. Hum Brain Mapp. 24:248-257. DOI.
• Devlin JT; Rushworth MF; Matthews PM. (2005). Category-related activation for written words in the posterior fusiform is task specific. Neuropsychologia. 43:69-74. DOI.
• Austin VC; Blamire AM; Allers KA; Sharp T; Styles P; Matthews PM; Sibson NR. (1 Jan 2005). Confounding effects of anesthesia on functional activation in rodent brain: a study of halothane and alpha-chloralose anesthesia. Neuroimage. 24:92-100. DOI.
• Johansen-Berg H; Behrens TE; Sillery E; Ciccarelli O; Thompson AJ; Smith SM; Matthews PM. (Jan 2005). Functional-anatomical validation and individual variation of diffusion tractography-based segmentation of the human thalamus. Cereb Cortex. 15:31-39. DOI.
• Bridge H; Clare S; Jenkinson M; Jezzard P; Parker AJ; Matthews PM. (2005). Independent anatomical and functional measures of the V1/V2 boundary in human visual cortex. J Vis. 5:93-102.
• Cardillo ER; Aydelott J; Matthews PM; Devlin JT. (Nov 2004). Left inferior prefrontal cortex activity reflects inhibitory rather than facilitatory priming. J Cogn Neurosci. 16:1552-1561. DOI.
• Ramnani N; Behrens TE; Penny W; Matthews PM. (1 Nov 2004). New approaches for exploring anatomical and functional connectivity in the human brain. Biol Psychiatry. 56:613-619. DOI.
• Chen JT; Narayanan S; Collins DL; Smith SM; Matthews PM; Arnold DL. (1 Nov 2004). Relating neocortical pathology to disability progression in multiple sclerosis using MRI. NEUROIMAGE. 23:1168-1175. Author weblink DOI.
• Devlin JT; Jamison HL; Matthews PM; Gonnerman LM. (12 Oct 2004). Morphology and the internal structure of words. Proc Natl Acad Sci U S A. 101:14984-14988. DOI.
• Floyer-Lea A; Matthews PM. (Oct 2004). Changing brain networks for visuomotor control with increased movement automaticity. J Neurophysiol. 92:2405-2412. DOI.
• Johansen-Berg H; Behrens TE; Robson MD; Drobnjak I; Rushworth MF; Brady JM; Smith SM; Higham DJ; et alMatthews PM. (7 Sep 2004). Changes in connectivity profiles define functionally distinct regions in human medial frontal cortex. Proc Natl Acad Sci U S A. 101:13335-13340. DOI.
• Völlm BA; de Araujo IE; Cowen PJ; Rolls ET; Kringelbach ML; Smith KA; Jezzard P; Heal RJ; et alMatthews PM. (Sep 2004). Methamphetamine activates reward circuitry in drug naïve human subjects. Neuropsychopharmacology. 29:1715-1722. DOI.
• Matthews PM. (1 Sep 2004). Primary progressive multiple sclerosis takes centre stage. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 75:1232-1233. Author weblink DOI.
• Abu-Omar Y; Cifelli A; Matthews PM; Taggart DP. (1 Sep 2004). The role of microembolisation in cerebral injury as defined by functional magnetic resonance imaging. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY. 26:586-590. Author weblink DOI.
• Matthews PM. (Aug 2004). An update on neuroimaging of multiple sclerosis. Curr Opin Neurol. 17:453-458.
• Arthurs OJ; Johansen-Berg H; Matthews PM; Boniface SJ. (1 Aug 2004). Attention differentially modulates the coupling of fMRI BOLD and evoked potential signal amplitudes in the human somatosensory cortex. EXPERIMENTAL BRAIN RESEARCH. 157:269-274. Author weblink DOI.
• Miller DH; Filippi M; Fazekas F; Frederiksen JL; Matthews PM; Montalban X; Polman CH. (1 Aug 2004). Role of magnetic resonance imaging within diagnostic criteria for multiple sclerosis. ANNALS OF NEUROLOGY. 56:273-278. Author weblink DOI.
• Saini S; DeStefano N; Smith S; Guidi L; Amato MP; Federico A; Matthews PM. (Jun 2004). Altered cerebellar functional connectivity mediates potential adaptive plasticity in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry. 75:840-846.
• Abu-Omar Y; Balacumaraswami L; Pigott DW; Matthews PM; Taggart DP. (Jun 2004). Solid and gaseous cerebral microembolization during off-pump, on-pump, and open cardiac surgery procedures. J Thorac Cardiovasc Surg. 127:1759-1765. DOI.
• Enzinger C; Ropele S; Smith S; Strasser-Fuchs S; Poltrum B; Schmidt H; Matthews PM; Fazekas F. (1 Apr 2004). Accelerated evolution of brain atrophy and "Black holes" in MS patients with APOE-epsilon 4. ANNALS OF NEUROLOGY. 55:563-569. Author weblink DOI.
• Bhagwagar Z; Wylezinska M; Taylor M; Jezzard P; Matthews PM; Cowen PJ. (Feb 2004). Increased brain GABA concentrations following acute administration of a selective serotonin reuptake inhibitor. Am J Psychiatry. 161:368-370.
• Sahyoun C; Floyer-Lea A; Johansen-Berg H; Matthews PM. (Feb 2004). Towards an understanding of gait control: brain activation during the anticipation, preparation and execution of foot movements. Neuroimage. 21:568-575. DOI.
• Smith SM; Jenkinson M; Woolrich MW; Beckmann CF; Behrens TE; Johansen-Berg H; Bannister PR; De Luca M; et alDrobnjak I; Flitney DE; Niazy RK; Saunders J; Vickers J; Zhang Y; De Stefano N; Brady JM; Matthews PM. (2004). Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage. 23 Suppl 1:S208-S219. DOI.
• Matthews PM. (1 Jan 2004). Finding landmarks for understanding white matter stroke. STROKE. 35:92-93. Author weblink.
• Matthews PM; Jezzard P. (Jan 2004). Functional magnetic resonance imaging. J Neurol Neurosurg Psychiatry. 75:6-12.
• Matthews PM; Johansen-Berg H; Reddy H. (2004). Non-invasive mapping of brain functions and brain recovery: applying lessons from cognitive neuroscience to neurorehabilitation. Restor Neurol Neurosci. 22:245-260.
• Devlin JT; Raley J; Tunbridge E; Lanary K; Floyer-Lea A; Narain C; Cohen I; Behrens T; et alJezzard P; Matthews PM; Moore DR. (17 Dec 2003). Functional asymmetry for auditory processing in human primary auditory cortex. J Neurosci. 23:11516-11522.
• Narain C; Scott SK; Wise RJ; Rosen S; Leff A; Iversen SD; Matthews PM. (Dec 2003). Defining a left-lateralized response specific to intelligible speech using fMRI. Cereb Cortex. 13:1362-1368.
• Parry AM; Scott RB; Palace J; Smith S; Matthews PM. (Dec 2003). Potentially adaptive functional changes in cognitive processing for patients with multiple sclerosis and their acute modulation by rivastigmine. Brain. 126:2750-2760. DOI.
• Behrens TE; Woolrich MW; Jenkinson M; Johansen-Berg H; Nunes RG; Clare S; Matthews PM; Brady JM; et alSmith SM. (Nov 2003). Characterization and propagation of uncertainty in diffusion-weighted MR imaging. Magn Reson Med. 50:1077-1088. DOI.
• Parry A; Matthews PM. (Oct 2003). Roles for imaging in understanding the pathophysiology, clinical evaluation, and management of patients with mitochondrial disease. J Neuroimaging. 13:293-302.
• Wegner C; Matthews PM. (1 Aug 2003). A new view of the cortex, new insights into multiple sclerosis. BRAIN. 126:1719-1721. Author weblink DOI.
• Parry A; Clare S; Jenkinson M; Smith S; Palace J; Matthews PM. (Jul 2003). MRI brain T1 relaxation time changes in MS patients increase over time in both the white matter and the cortex. J Neuroimaging. 13:234-239.
• Behrens TE; Johansen-Berg H; Woolrich MW; Smith SM; Wheeler-Kingshott CA; Boulby PA; Barker GJ; Sillery EL; et alSheehan K; Ciccarelli O; Thompson AJ; Brady JM; Matthews PM. (Jul 2003). Non-invasive mapping of connections between human thalamus and cortex using diffusion imaging. Nat Neurosci. 6:750-757. DOI.
• Wylezinska M; Cifelli A; Jezzard P; Palace J; Alecci M; Matthews PM. (24 Jun 2003). Thalamic neurodegeneration in relapsing-remitting multiple sclerosis. Neurology. 60:1949-1954.
• Austin VC; Blamire AM; Grieve SM; O'Neill MJ; Styles P; Matthews PM; Sibson NR. (May 2003). Differences in the BOLD fMRI response to direct and indirect cortical stimulation in the rat. Magn Reson Med. 49:838-847. DOI.
• Matthews PM; Adcock J; Chen Y; Fu S; Devlin JT; Rushworth MF; Smith S; Beckmann C; et alIversen S. (Mar 2003). Towards understanding language organisation in the brain using fMRI. Hum Brain Mapp. 18:239-247. DOI.
• Parry A; Corkill R; Blamire AM; Palace J; Narayanan S; Arnold D; Styles P; Matthews PM. (Feb 2003). Beta-Interferon treatment does not always slow the progression of axonal injury in multiple sclerosis. J Neurol. 250:171-178. DOI.
• Adcock JE; Wise RG; Oxbury JM; Oxbury SM; Matthews PM. (Feb 2003). Quantitative fMRI assessment of the differences in lateralization of language-related brain activation in patients with temporal lobe epilepsy. Neuroimage. 18:423-438.
• Devlin JT; Matthews PM; Rushworth MF. (1 Jan 2003). Semantic processing in the left inferior prefrontal cortex: a combined functional magnetic resonance imaging and transcranial magnetic stimulation study. J Cogn Neurosci. 15:71-84. DOI.
• Johansen-Berg H; Dawes H; Guy C; Smith SM; Wade DT; Matthews PM. (Dec 2002). Correlation between motor improvements and altered fMRI activity after rehabilitative therapy. Brain. 125:2731-2742.
• Reddy H; Narayanan S; Woolrich M; Mitsumori T; Lapierre Y; Arnold DL; Matthews PM. (Dec 2002). Functional brain reorganization for hand movement in patients with multiple sclerosis: defining distinct effects of injury and disability. Brain. 125:2646-2657.
• Smith KA; Ploghaus A; Cowen PJ; McCleery JM; Goodwin GM; Smith S; Tracey I; Matthews PM. (Nov 2002). Cerebellar responses during anticipation of noxious stimuli in subjects recovered from depression. Functional magnetic resonance imaging study. Br J Psychiatry. 181:411-415.
• Fu S; Chen Y; Smith S; Iversen S; Matthews PM. (Nov 2002). Effects of word form on brain processing of written Chinese. Neuroimage. 17:1538-1548.
• Cifelli A; Arridge M; Jezzard P; Esiri MM; Palace J; Matthews PM. (Nov 2002). Thalamic neurodegeneration in multiple sclerosis. Ann Neurol. 52:650-653. DOI.
• Johansen-Berg H; Rushworth MF; Bogdanovic MD; Kischka U; Wimalaratna S; Matthews PM. (29 Oct 2002). The role of ipsilateral premotor cortex in hand movement after stroke. Proc Natl Acad Sci U S A. 99:14518-14523. DOI.
• Chen Y; Fu S; Iversen SD; Smith SM; Matthews PM. (1 Oct 2002). Testing for dual brain processing routes in reading: a direct contrast of chinese character and pinyin reading using FMRI. J Cogn Neurosci. 14:1088-1098. DOI.
• Smith SM; Zhang Y; Jenkinson M; Chen J; Matthews PM; Federico A; De Stefano N. (Sep 2002). Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage. 17:479-489.
• Parry A; Clare S; Jenkinson M; Smith S; Palace J; Matthews PM. (Sep 2002). White matter and lesion T1 relaxation times increase in parallel and correlate with disability in multiple sclerosis. J Neurol. 249:1279-1286. DOI.
• Parry A; Corkill R; Blamire A; Palace J; Narayanan S; Arnold D; Styles P; Matthews PM. (1 Aug 2002). beta-interferon treatment does not immediately slow the progression of axonal injury in multiple sclerosis. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 73:214-214. Author weblink.
• Cifelli A; Matthews PM. (May 2002). Cerebral plasticity in multiple sclerosis: insights from fMRI. Mult Scler. 8:193-199.
• Matthews PM. (1 May 2002). White matter change and stroke risk. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 72:564-565. Author weblink DOI.
• Arnold DL; Matthews PM. (23 Apr 2002). MRI in the diagnosis and management of multiple sclerosis. NEUROLOGY. 58:S23-S31. Author weblink.
• Tracey I; Ploghaus A; Gati JS; Clare S; Smith S; Menon RS; Matthews PM. (1 Apr 2002). Imaging attentional modulation of pain in the periaqueductal gray in humans. J Neurosci. 22:2748-2752.
• Rocca MA; Matthews PM; Caputo D; Ghezzi A; Falini A; Scotti G; Comi G; Filippi M. (26 Mar 2002). Evidence for widespread movement-associated functional MRI changes in patients with PPMS. NEUROLOGY. 58:866-872. Author weblink.
• Reddy H; Bendahan D; Lee MA; Johansen-Berg H; Donaghy M; Hilton-Jones D; Matthews PM. (Feb 2002). An expanded cortical representation for hand movement after peripheral motor denervation. J Neurol Neurosurg Psychiatry. 72:203-210.
• Reddy H; De Stefano N; Mortilla M; Federico A; Matthews PM. (Feb 2002). Functional reorganization of motor cortex increases with greater axonal injury from CADASIL. Stroke. 33:502-508.
• Stevenson VL; Smith SM; Matthews PM; Miller DH; Thompson AJ. (1 Feb 2002). Monitoring disease activity and progression in primary progressive multiple sclerosis using MRI: sub-voxel registration to identify lesion changes and to detect cerebral atrophy. JOURNAL OF NEUROLOGY. 249:171-177. Author weblink DOI.
• Pineiro R; Pendlebury S; Johansen-Berg H; Matthews PM. (Jan 2002). Altered hemodynamic responses in patients after subcortical stroke measured by functional MRI. Stroke. 33:103-109.
• Johansen-Berg H; Matthews PM. (Jan 2002). Attention to movement modulates activity in sensori-motor areas, including primary motor cortex. Exp Brain Res. 142:13-24. DOI.
• Parry A; Matthews PM. (1 Mar 2002). Functional magnetic resonance imaging: a window into the brain. INTERDISCIPLINARY SCIENCE REVIEWS. 27:50-60. Author weblink DOI.
• Lane RD; Tracey I; Wise R; Fort C; Longe S; Matthews PM. (1 Jan 2002). Overlapping neural substrates of the experience and anticipation of pain and aversive emotion. PSYCHOSOMATIC MEDICINE. 64:112-112. Author weblink.
• Ploghaus A; Narain C; Beckmann CF; Clare S; Bantick S; Wise R; Matthews PM; Rawlins JN; et alTracey I. (15 Dec 2001). Exacerbation of pain by anxiety is associated with activity in a hippocampal network. J Neurosci. 21:9896-9903.
• Matthews PM. (1 Nov 2001). Editorial commentary to Narayanan et al. JOURNAL OF NEUROLOGY. 248:987-987. Author weblink DOI.
• Piñeiro R; Matthews PM. (16 Oct 2001). [Cerebral vasoreactivity and functional response in stroke: a study with functional MR]. Rev Neurol. 33:701-708.
• Evangelou N; Konz D; Esiri MM; Smith S; Palace J; Matthews PM. (Sep 2001). Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosis. Brain. 124:1813-1820.
• Matthews PM; Wylezinska M; Cadoux-Hudson T. (Aug 2001). Novel approaches to imaging brain tumors. Hematol Oncol Clin North Am. 15:609-630.
• Pineiro R; Matthews PM; Maestu C; Bardasano JL. (1 Jul 2001). Functional magnetic resonance and the motor cortex. II. Measurement of activity. REVISTA DE NEUROLOGIA. 33:1-6. Author weblink.
• Pineiro R; Matthews PM; Maestu C; Bardasano JL. (16 Jun 2001). Functional magnetic resonance and the cerebral cortex I. Group analysis. REVISTA DE NEUROLOGIA. 32:1101-1106. Author weblink.
• Floyer AM; Reddy H; Parry A; Donaghy M; Matthews PM. (1 Jun 2001). Altered cortical activation with finger movement after peripheral denervation: Comparison of active and passive tasks. NEUROIMAGE. 13:S791-S791. Author weblink.
• Reddy H; Floyer A; Donaghy M; Matthews PM. (Jun 2001). Altered cortical activation with finger movement after peripheral denervation: comparison of active and passive tasks. Exp Brain Res. 138:484-491.
• Reddy H; Lassonde R; Matthews PM; Arnold D. (1 Jun 2001). An fMRI study of the role of the corpus callosum in ipsilateral motor activation. NEUROIMAGE. 13:S1242-S1242. Author weblink.
• Sahyoun C; Matthews PM. (1 Jun 2001). Application of passive leg movement to FMRI analysis of gait. NEUROIMAGE. 13:S1247-S1247. Author weblink.
• Johansen-Berg H; Matthews PM. (1 Jun 2001). Attention to movement modulates activity in primary motor cortex. NEUROIMAGE. 13:S324-S324. Author weblink.
• Adcock JE; Smith SM; Matthews PM. (1 Jun 2001). Comparison of fMRI with the Wada test for lateralisation of language in pre-surgical epilepsy patients. NEUROIMAGE. 13:S766-S766. Author weblink.
• Narain C; Scott SK; Leff A; Matthews PM; Iversen SD; Wise R. (1 Jun 2001). Left lateralised response specific to intelligible speech: an fMRI study. NEUROIMAGE. 13:S576-S576. Author weblink.
• Matthews PM; Arnold DL. (Jun 2001). Magnetic resonance imaging of multiple sclerosis: new insights linking pathology to clinical evolution. Curr Opin Neurol. 14:279-287.
• Smith S; Zhang YY; Jenkinson M; Matthews PM; De Stefano N. (1 Jun 2001). SIENA: Single and multiple time point brain atrophy analysis. NEUROIMAGE. 13:S250-S250. Author weblink.
• Pineiro R; Pendlebury S; Johansen-Berg H; Matthews PM. (May 2001). Functional MRI detects posterior shifts in primary sensorimotor cortex activation after stroke: evidence of local adaptive reorganization?. Stroke. 32:1134-1139.
• Smith SM; De Stefano N; Jenkinson M; Matthews PM. (May 2001). Normalized accurate measurement of longitudinal brain change. J Comput Assist Tomogr. 25:466-475.
• De Stefano N; Narayanan S; Francis GS; Arnaoutelis R; Tartaglia MC; Antel JP; Matthews PM; Arnold DL. (1 Jan 2001). Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability. ARCHIVES OF NEUROLOGY. 58:65-70. Author weblink DOI.
• Matthews PM; De Stefano N; Fazekas F; Filippi M; Miller D; Seitz RJ. (1 Jan 2001). The future of magnetic resonance-based techniques in neurology. EUROPEAN JOURNAL OF NEUROLOGY. 8:17-25. Author weblink.
• Piñeiro R; Matthews PM. (16 Nov 2000). [Introduction to functional magnetic resonance]. Rev Neurol. 31:983-991.
• Reddy H; Narayanan S; Arnoutelis R; Jenkinson M; Antel J; Matthews PM; Arnold DL. (1 Nov 2000). Evidence for adaptive functional changes in the cerebral cortex with axonal injury from multiple sclerosis. BRAIN. 123:2314-2320. Author weblink DOI.
• Arnold DL; De Stefano N; Narayanan S; Matthews PM. (1 Nov 2000). Proton MR spectroscopy in multiple sclerosis. NEUROIMAGING CLINICS OF NORTH AMERICA. 10:789-+. Author weblink.
• Evangelou N; Konz D; Esiri MM; Smith S; Palace J; Matthews PM. (Sep 2000). Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis. Brain. 123 ( Pt 9):1845-1849.
• Reddy H; Lassonde M; Bemasconi N; Bemasconi A; Matthews PM; Andermann F; Amold DL. (3 Aug 2000). An fMRI study of the lateralization of motor cortex activation in acallosal patients. Neuroreport. 11:2409-2413.
• Ploghaus A; Tracey I; Clare S; Gati JS; Rawlins JN; Matthews PM. (1 Aug 2000). Learning about pain: the neural substrate of the prediction error for aversive events. Proc Natl Acad Sci U S A. 97:9281-9286. DOI.
• Devlin JT; Russell RP; Davis MH; Price CJ; Wilson J; Moss HE; Matthews PM; Tyler LK. (1 Jun 2000). Susceptibility-induced loss of signal: Comparing PET and fMRI on a semantic task. NEUROIMAGE. 11:589-600. Author weblink DOI.
• Pendlebury ST; Lee MA; Blamire AM; Styles P; Matthews PM. (May 2000). Correlating magnetic resonance imaging markers of axonal injury and demyelination in motor impairment secondary to stroke and multiple sclerosis. Magn Reson Imaging. 18:369-378.
• Lee M; Reddy H; Johansen-Berg H; Pendlebury S; Jenkinson M; Smith S; Palace J; Matthews PM. (May 2000). The motor cortex shows adaptive functional changes to brain injury from multiple sclerosis. Ann Neurol. 47:606-613.
• Johansen-Berg H; Christensen V; Woolrich M; Matthews PM. (27 Apr 2000). Attention to touch modulates activity in both primary and secondary somatosensory areas. Neuroreport. 11:1237-1241.
• Evangelou N; Esiri MM; Smith S; Palace J; Matthews PM. (Mar 2000). Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis. Ann Neurol. 47:391-395.
• Pineiro R; Pendlebury ST; Smith S; Flitney D; Blamire AM; Styles P; Matthews PM. (Mar 2000). Relating MRI changes to motor deficit after ischemic stroke by segmentation of functional motor pathways. Stroke. 31:672-679.
• Calvert GA; Brammer MJ; Morris RG; Williams SC; King N; Matthews PM. (15 Feb 2000). Using fMRI to study recovery from acquired dysphasia. Brain Lang. 71:391-399. DOI.
• Taivassalo T; Reddy H; Matthews PM. (1 Feb 2000). Muscle responses to exercise in health and disease. NEUROLOGIC CLINICS. 18:15-+. Author weblink DOI.
• Reddy H; Narayanan S; Matthews PM; Hoge RD; Pike GB; Duquette P; Antel J; Arnold DL. (11 Jan 2000). Relating axonal injury to functional recovery in MS. NEUROLOGY. 54:236-239. Author weblink.
• Lee MA; Blamire AM; Pendlebury S; Ho KH; Mills KR; Styles P; Palace J; Matthews PM. (Jan 2000). Axonal injury or loss in the internal capsule and motor impairment in multiple sclerosis. Arch Neurol. 57:65-70.
• Pendlebury ST; Johansen-Berg H; Lee MA; Matthews PM. (1 Jan 2000). Functional magnetic resonance imaging of simple and complex hand tasks after ischemic motor stroke. STROKE. 31:291-291. Author weblink.
• Matthews PM. (1 Dec 1999). Axonal loss and demyelation in multiple sclerosis. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 67:708-709. Author weblink DOI.
• Griffin JL; Rae C; Radda GK; Matthews PM. (Nov 1999). Lactate-induced inhibition of glucose catabolism in guinea pig cortical brain slices. Neurochem Int. 35:405-409.
• De Stefano N; Narayanan S; Matthews PM; Francis GS; Antel JP; Arnold DL. (1 Oct 1999). In vivo evidence for axonal dysfunction remote from focal cerebral demyelination of the type seen in multiple sclerosis. BRAIN. 122:1933-1939. Author weblink DOI.
• Morten KJ; Beattie P; Brown GK; Matthews PM. (11 Aug 1999). Dichloroacetate stabilizes the mutant E1alpha subunit in pyruvate dehydrogenase deficiency. Neurology. 53:612-616.
• Griffin JL; Rae C; Radda GK; Matthews PM. (8 Jul 1999). Delayed labelling of brain glutamate after an intra-arterial [13C]glucose bolus: evidence for aerobic metabolism of guinea pig brain glycogen store. Biochim Biophys Acta. 1450:297-307.
• Lee MA; Smith S; Palace J; Narayanan S; Silver N; Minicucci L; Filippi M; Miller DH; et alArnold DL; Matthews PM. (Jul 1999). Spatial mapping of T2 and gadolinium-enhancing T1 lesion volumes in multiple sclerosis: evidence for distinct mechanisms of lesion genesis?. Brain. 122 ( Pt 7):1261-1270.
• Ploghaus A; Tracey I; Gati JS; Clare S; Menon RS; Matthews PM; Rawlins JN. (18 Jun 1999). Dissociating pain from its anticipation in the human brain. Science. 284:1979-1981.
• Matthews PM; Clare S; Adcock J. (Jun 1999). Functional magnetic resonance imaging: clinical applications and potential. J Inherit Metab Dis. 22:337-352.
• Pendlebury ST; Blamire AM; Lee MA; Styles P; Matthews PM. (1 May 1999). Axonal injury in the internal capsule correlates with motor impairment after stroke. STROKE. 30:956-962. Author weblink.
• Nagy Z; Esiri MM; LeGris M; Matthews PM. (Apr 1999). Mitochondrial enzyme expression in the hippocampus in relation to Alzheimer-type pathology. Acta Neuropathol. 97:346-354.
• Griffin JL; Rae C; Dixon RM; Radda GK; Matthews PM. (Dec 1998). Excitatory amino acid synthesis in hypoxic brain slices: does alanine act as a substrate for glutamate production in hypoxia?. J Neurochem. 71:2477-2486.
• Lee MA; Smith S; Palace J; Matthews PM. (1 Nov 1998). Defining multiple sclerosis disease activity using MRI T-2-weighted difference imaging. BRAIN. 121:2095-2102. Author weblink DOI.
• Morten KJ; Caky M; Matthews PM. (Nov 1998). Mechanisms of expression of pyruvate dehydrogenase deficiency caused by an E1alpha subunit mutation. Neurology. 51:1324-1330.
• Morten KJ; Caky M; Matthews PM. (Nov 1998). Stabilization of the pyruvate dehydrogenase E1alpha subunit by dichloroacetate. Neurology. 51:1331-1335.
• De Stefano N; Matthews PM; Fu LQ; Narayanan S; Stanley J; Francis GS; Antel JP; Arnold DL. (1 Aug 1998). Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis - Results of a longitudinal magnetic resonance spectroscopy study. BRAIN. 121:1469-1477. Author weblink DOI.
• Fu L; Matthews PM; De Stefano N; Worsley KJ; Narayanan S; Francis GS; Antel JP; Wolfson C; et alArnold DL. (1 Jan 1998). Imaging axonal damage of normal-appearing white matter in multiple sclerosis. BRAIN. 121:103-113. Author weblink DOI.
• Matthews PM; De Stefano N; Narayanan S; Francis GS; Wolinsky JS; Antel JP; Arnold DL. (1998). Putting magnetic resonance spectroscopy studies in context: axonal damage and disability in multiple sclerosis. Semin Neurol. 18:327-336. DOI.
• Cendes F; Andermann F; Dubeau F; Matthews PM; Arnold DL. (1 Dec 1997). Normalization of neuronal metabolic dysfunction after surgery for temporal lobe epilepsy - Evidence from proton MR spectroscopic imaging. NEUROLOGY. 49:1525-1533. Author weblink.
• DeStefano N; Matthews PM; Narayanan S; Francis GS; Antel JP; Arnold DL. (1 Oct 1997). Axonal dysfunction and disability in a relapse of multiple sclerosis: Longitudinal study of a patient. NEUROLOGY. 49:1138-1141. Author weblink.
• Otero LJ; Brown GK; Silver K; Arnold DL; Matthews PM. (Nov 1995). Association of cerebral dysgenesis and lactic acidemia with X-linked PDH E1 alpha subunit mutations in females. Pediatr Neurol. 13:327-332.
• MATTHEWS PM; BROWN RM; MORTEN K; MARCHINGTON D; POULTON J; BROWN G. (1 Sep 1995). INTRACELLULAR HETEROPLASMY FOR DISEASE-ASSOCIATED POINT MUTATIONS IN MTDNA - IMPLICATIONS FOR DISEASE EXPRESSION AND EVIDENCE FOR MITOTIC SEGREGATION OF HETEROPLASMIC UNITS OF MTDNA. HUMAN GENETICS. 96:261-268. Author weblink.
• MATTHEWS PM; BENJAMIN D; VANBAKEL I; SQUIER MV; NICHOLSON LVB; SEWRY C; BARNES PRJ; HOPKIN J; et alBROWN R; HILTONJONES D; BOYD Y; KARPATI G; BROWN GK; CRAIG IW. (1 May 1995). MUSCLE X-INACTIVATION PATTERNS AND DYSTROPHIN EXPRESSION IN DUCHENNE MUSCULAR-DYSTROPHY CARRIERS. NEUROMUSCULAR DISORDERS. 5:209-220. Author weblink DOI.
• Matthews PM; Squier MV; Chalk C; Donaghy M. (Jan 1995). Mitochondrial abnormalities are not invariably present in neurologic syndromes associated with multiple symmetric lipomatosis. Neurology. 45:197-198.
• SHEVELL MI; MATTHEWS PM; SCRIVER CR; BROWN RM; OTERO LJ; LEGRIS M; BROWN GK; ARNOLD DL. (1 Oct 1994). CEREBRAL DYSGENESIS AND LACTIC ACIDEMIA - AN MRI/MRS PHENOTYPE ASSOCIATED WITH PYRUVATE-DEHYDROGENASE DEFICIENCY. PEDIATRIC NEUROLOGY. 11:224-229. Author weblink DOI.
• FUJII T; VANCOSTER RN; OLD SE; MEDORI R; WINTER S; GUBITS RM; MATTHEWS PM; BROWN RM; et alBROWN GK; DAHL HHM; DEVIVO DC. (1 Jul 1994). PYRUVATE-DEHYDROGENASE DEFICIENCY - MOLECULAR-BASIS FOR INTRAFAMILIAL HETEROGENEITY. ANNALS OF NEUROLOGY. 36:83-89. Author weblink DOI.
• Matthews PM; Brown RM; Otero LJ; Marchington DR; LeGris M; Howes R; Meadows LS; Shevell M; et alScriver CR; Brown GK. (Jun 1994). Pyruvate dehydrogenase deficiency. Clinical presentation and molecular genetic characterization of five new patients. Brain. 117 ( Pt 3):435-443.
• MATTHEWS PM; BROWN RM; OTERO LJ; MARCHINGTON DR; LEGRIS M; HOWES R; MEADOWS LS; SHEVELL M; et alSCRIVER CR; BROWN GK. (1 Jun 1994). PYRUVATE-DEHYDROGENASE DEFICIENCY - CLINICAL PRESENTATION AND MOLECULAR-GENETIC CHARACTERIZATION OF 5 NEW PATIENTS. BRAIN. 117:435-443. Author weblink DOI.
• Matthews PM; Nagy Z; Brown GK; Land J; Squier MV. (May 1994). Isolated capillary proliferation in Leigh's syndrome. Clin Neuropathol. 13:139-141.
• Matthews PM; Hopkin J; Brown RM; Stephenson JB; Hilton-Jones D; Brown GK. (Jan 1994). Comparison of the relative levels of the 3243 (A-->G) mtDNA mutation in heteroplasmic adult and fetal tissues. J Med Genet. 31:41-44.
• MATTHEWS PM; ANDERMANN F; SILVER K; KARPATI G; ARNOLD DL. (1 Dec 1993). PROTON MR SPECTROSCOPIC CHARACTERIZATION OF DIFFERENCES IN REGIONAL BRAIN METABOLIC ABNORMALITIES IN MITOCHONDRIAL ENCEPHALOMYOPATHIES. NEUROLOGY. 43:2484-2490. Author weblink.
• Matthews PM; Brown RM; Otero L; Marchington D; Leonard JV; Brown GK. (Oct 1993). Neurodevelopmental abnormalities and lactic acidosis in a girl with a 20-bp deletion in the X-linked pyruvate dehydrogenase E1 alpha subunit gene. Neurology. 43:2025-2030.
• Matthews PM; Marchington DR; Squier M; Land J; Brown RM; Brown GK. (Jun 1993). Molecular genetic characterization of an X-linked form of Leigh's syndrome. Ann Neurol. 33:652-655. DOI.
• MATTHEWS PM. (1 Oct 1991). MYOTONIC-DYSTROPHY - OBSERVATIONS ON THE PHENOTYPE. AMERICAN JOURNAL OF HUMAN GENETICS. 49:82-82. Author weblink.
• MALLOY CR; MATTHEWS PM; SMITH MB; RADDA GK. (1 Oct 1986). INFLUENCE OF PROPRANOLOL ON ACIDOSIS AND HIGH-ENERGY PHOSPHATES IN ISCHEMIC MYOCARDIUM OF THE RABBIT. CARDIOVASCULAR RESEARCH. 20:710-720. Author weblink DOI.
• TAYLOR DJ; MATTHEWS PM; RADDA GK. (1 Mar 1986). MYOGLOBIN-DEPENDENT OXIDATIVE-METABOLISM IN THE HYPOXIC RAT-HEART. RESPIRATION PHYSIOLOGY. 63:275-283. Author weblink DOI.
• TAYLOR DJ; STYLES P; MATTHEWS PM; ARNOLD DA; GADIAN DG; BORE P; RADDA GK. (1 Feb 1986). ENERGETICS OF HUMAN-MUSCLE - EXERCISE-INDUCED ATP DEPLETION. MAGNETIC RESONANCE IN MEDICINE. 3:44-54. Author weblink DOI.
• MATTHEWS PM; TAYLOR DJ; RADDA GK. (1 Jan 1986). BIOCHEMICAL-MECHANISMS OF ACUTE CONTRACTILE FAILURE IN THE HYPOXIC RAT-HEART. CARDIOVASCULAR RESEARCH. 20:13-19. Author weblink DOI.
• ARNOLD DL; MATTHEWS PM; RADDA GK. (1 Jan 1984). APPLICATION OF P-31 NMR TO ASSESSMENT OF MITOCHONDRIAL-FUNCTION IN HUMAN SKELETAL-MUSCLE. MAGNETIC RESONANCE IN MEDICINE. 1:90-90. Author weblink.
• RADDA GK; TAYLOR DJ; STYLES P; BORE PJ; MATTHEWS PM; GADIAN DG. (1 Jan 1984). EXERCISE-INDUCED ATP DEPLETION IN NORMAL HUMAN-MUSCLE. MAGNETIC RESONANCE IN MEDICINE. 1:229-229. Author weblink.
• MALLOY CR; MATTHEWS PM; SMITH MB; RADDA GK. (1 Jan 1984). INFLUENCE OF PROPRANOLOL ON THE RESPONSE TO REGIONAL CARDIAC ISCHEMIA MONITORED INVIVO BY P-31 NUCLEAR MAGNETIC-RESONANCE SPECTROSCOPY. CLINICAL RESEARCH. 32:A187-A187. Author weblink.
• ARNOLD DL; MATTHEWS PM; RADDA GK. (1 Jan 1984). METABOLIC RECOVERY AFTER EXERCISE AND THE ASSESSMENT OF MITOCHONDRIAL-FUNCTION INVIVO IN HUMAN SKELETAL-MUSCLE BY MEANS OF P-31 NMR. MAGNETIC RESONANCE IN MEDICINE. 1:307-315. Author weblink DOI.
• MATTHEWS PM; BLAND JL; RADDA GK. (1 Jan 1983). THE TEMPERATURE-DEPENDENCE OF CREATINE-KINASE FLUXES IN THE RAT-HEART. BIOCHIMICA ET BIOPHYSICA ACTA. 763:140-146. Author weblink DOI.
• MATTHEWS PM; BLAND JL; GADIAN DG; RADDA GK. (1 Jan 1982). A P-31-NMR SATURATION TRANSFER STUDY OF THE REGULATION OF CREATINE-KINASE IN THE RAT-HEART. BIOCHIMICA ET BIOPHYSICA ACTA. 721:312-320. Author weblink DOI.
• MATTHEWS PM; WILLIAMS S; SEYMOUR AM; SCHWARTZ A; DUBE G; GADIAN DG; RADDA GK. (1 Jan 1982). A P-31-NMR STUDY OF SOME METABOLIC AND FUNCTIONAL-EFFECTS OF THE INOTROPIC AGENTS EPINEPHRINE AND OUABAIN, AND THE IONOPHORE RO2-2985 (X537A) IN THE ISOLATED, PERFUSED RAT-HEART. BIOCHIMICA ET BIOPHYSICA ACTA. 720:163-171. Author weblink DOI.
• THULBORN KR; WATERTON JC; MATTHEWS PM; RADDA GK. (1 Jan 1982). OXYGENATION DEPENDENCE OF THE TRANSVERSE RELAXATION-TIME OF WATER PROTONS IN WHOLE-BLOOD AT HIGH-FIELD. BIOCHIMICA ET BIOPHYSICA ACTA. 714:265-270. DOI.
• MATTHEWS PM; BLAND JL; GADIAN DG; RADDA GK. (1 Jan 1981). A 31-P NMR SATURATION TRANSFER STUDY OF THE REGULATION OF CREATINE-KINASE IN THE PERFUSED RAT-HEART. FEDERATION PROCEEDINGS. 40:1625-1625. Author weblink.
• BAILEY IA; GADIAN DG; MATTHEWS PM; RADDA GK; SEELEY PJ. (1 Jan 1981). STUDIES OF METABOLISM IN THE ISOLATED, PERFUSED RAT-HEART USING C-13 NMR. FEBS LETTERS. 123:315-318. Author weblink DOI.
• MATTHEWS PM; BLAND JL; GADIAN DG; RADDA GK. (1 Jan 1981). THE STEADY-STATE RATE OF ATP SYNTHESIS IN THE PERFUSED RAT-HEART MEASURED BY P-31 NMR SATURATION TRANSFER. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 103:1052-1059. Author weblink DOI.
• WILLIAMS S; MATTHEWS PM; SCHWARTZ A; RADDA GK. (1 Jan 1980). THE RELATIONSHIP BETWEEN PRESSURE DEVELOPMENT INDUCED BY INOTROPIC AGENTS, AND HIGH-ENERGY PHOSPHATE-COMPOUNDS IN THE LANGENDORF (L) PERFUSED RAT-HEART - A P-31-NMR STUDY. FEDERATION PROCEEDINGS. 39:2113-2113. Author weblink.

Books

• Nalbantian S; Matthews PM; McClelland JL. The Memory Process. . Mit Pr (2010).

Conferences

• Colasanti A; Searle GE; Long CJ; Hill SP; Reiley RR; Tziortzi AC; Quelch D; Gunn R; et alWaldman AD; Schruers KJ; Matthews PM; Nutt DJ; Rabiner EA. OPIOID RELEASE IN HUMAN BRAIN REWARD SYSTEM INDUCED BY AN ACUTE AMPHETAMINE CHALLENGE: A [11C]CARFENTANIL PET STUDY. Summer Meeting of the British-Association-for-Psychopharmacology, 24 Jul 2011 - 27 Jul 2011. 25:A60-A60. SAGE PUBLICATIONS LTD (1 Aug 2011). Author weblink.
• Matthews PM; Fu SM; Chen YP; Iversen S. Functional magnetic resonance imaging: A promising tool for defining the organization of Chinese language in the brain. International Symposium on Cognitive Processes of the Chinese Language, 29 Aug 1997 - 2 Sep 1997. 61-77. UNIV WASHINGTON PRESS (1 Jan 2002).
• Owen DR; Rabiner EA; Gunn RN; Matthews PM; Parker CA. PBR28, PBR06 and PBR111 bind two distinct TSPO sites in human brain tissue. 8th International Symposium on Functional Neuroreceptor Mapping of the Living Brain, 22 Jul 2010 - 24 Jul 2010. 52:S30-S31. ACADEMIC PRESS INC ELSEVIER SCIENCE (1 Aug 2010). DOI.
• Zarei M; Menke RA; Scholz J; Miller K; Deoni S; Jbabdi S; Matthews PM. Multimodal MR imaging of substantia nigra in Parkinson's disease. 19th World Congress of Neurology, 24 Oct 2009 - 30 Oct 2009. 285:S293-S293. ELSEVIER SCIENCE BV (1 Oct 2009). Author weblink.
• Tomassini V; Johansen-Berg H; Leonardi L; Palace J; Pozzilli C; Matthews PM. MOTOR SKILL LEARNING IN MULTIPLE SCLEROSIS. ABN Joint Annual Meeting/Spanish-Society-of-Neurology, 22 Jun 2009 - 26 Jun 2009. 80. B M J PUBLISHING GROUP (1 Nov 2009). Author weblink DOI.
• Long CJ; Cole DM; Durcan MJ; Matthews PM; Beaver JD. DYNAMIC IMAGING OF COGNITIVE IMPAIRMENT IN NICOTINE-DEPRIVED SUBJECTS USING SIMULTANEOUS EEG/FMRI. IEEE Internaional Symposium on Biomedical Imaging - From Nano to Macro, 28 Jun 2009 - 1 Jul 2009. 646-649. IEEE (1 Jan 2009). Author weblink DOI.
• Filippi M; Rocca MA; Absinta M; Valsasina P; Ciccarelli O; Marino S; Rovira A; Gass A; et alWegner C; Enzinger C; Korteweg T; Mancini L; Thompson A; De Stefano N; Montalban X; Hirsch J; Kappos L; Ropele S; Palace J; Barkhof F; Yousry T; Matthews PM. Functional connectivity changes of the motor network in patients with multiple sclerosis: a multi-centre fMRI study. 19th Meeting of the European-Neurological-Society, 20 Jun 2009 - 24 Jun 2009. 256:S47-S48. DR DIETRICH STEINKOPFF VERLAG (1 Jun 2009). Author weblink.
• Bosnell RA; Kincses T; Kischka U; Matthews PM; Johansen-Berg H. DTI MEASURES OF WHITE MATTER INTEGRITY PREDICT RESPONSE TO MOTOR TRAINING POST STROKE. Spring Scientific Meeting of the Association-of-British-Neurologists, 26 Mar 2008 - 28 Jun 2008. 80:118-119. B M J PUBLISHING GROUP (1 Jan 2009). Author weblink.
• Bendfeldt K; Kuster P; Traud S; Egger H; Winklhofer S; Mueller-Lenke N; Naegelin Y; Gass A; et alKappos L; Matthews PM; Nichols TE; Radue E-W; Borgwardt SJ. Association of regional gray matter volume loss and progressive white matter lesions in multiple sclerosis. 13th Annual Meeting of the Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/24th Congress of the European-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/5th Congress of the Latin-Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis, 17 Sep 2008 - 20 Sep 2008. 14:S95-S96. SAGE PUBLICATIONS LTD (1 Sep 2008). Author weblink.
• Rocca M; Absinta M; Valsasina P; Ciccarelli O; Thompson AJ; Mancini L; Marino S; De Stefano N; et alRovira A; Montalban X; Gass A; Kappos L; Wegner C; Enzinger C; Ropele S; Korteweg T; Barkhof F; Matthews PM; Filippi M. Abnormal connectivity inside the motor network in patients with multiple sclerosis: a multicentre fMRI study. 18th Meeting of the European-Neurological-Society, 7 Jun 2008 - 11 Jun 2008. 255:8-8. SPRINGER HEIDELBERG (1 Jun 2008). Author weblink.
• Giorgio A; Watkins KE; Douaud G; Behrens TE; Matthews PM; James AC; James S; Smith SM; et alJohansen-Berg H. Developmental changes in white matter microstructure in adolescence. ABN Spring Scientific Meeting 2007. 78:1019-1020. (Sep 2007).
• Tomassini V; Jbabdi S; Klein JC; Behrens TE; Rushworth M; Matthews PM; Palace J; Johansen-Berg H. Diffusion tensor imaging defines subregions of human lateral premotor cortex with distinct frontoparietal connections. ABN Spring Scientific Meeting 2007, 11 Apr 2007 - 13 Apr 2007. 78:1028-1028. B M J PUBLISHING GROUP (1 Sep 2007). Author weblink.
• Stagg CJ; Kincses ZT; Palace J; Matthews PM; Johansen-Berg H. Transcranial direct current stimulation: A potential tool for rehabilitation?. ABN Spring Scientific Meeting 2007. 78:1036-1036. (Sep 2007).
• Bhagwagar Z; Wylezinska M; Jezzard P; Evans J; Ashworth F; Sule A; Matthews PM; Cowen PJ. Reduction in occipital cortex GABA concentrations in medication free recovered bipolar subjects. International Conference on Bipolar Disorder. 9:21-21. (Jun 2007).
• Pomeroy IM; Jordan EK; Frank J; Matthews PM; Esiri MM. Neurodegeneration in a marmoset model of multiple sclerosis. Spring Meeting of the Association-of-British-Neurologists, 19 Apr 2006 - 21 Apr 2006. 77:1399-1399. B M J PUBLISHING GROUP (1 Dec 2006). Author weblink.
• Nenadic I; Schlosser R; Wagner G; Behrens T; Von Consbruch K; Schultz CC; Koch K; Kohler S; et alGullmar D; Fitzek C; Reichenbach JR; Matthews PM; Sauer H. Combined imaging of white matter and brain activation in schizophrenia with DTI and fMRI: Evidence for temporolimbic and prefrontal alterations. 13th Biennial Winter Workshop on Schizophrenia Research. 81:150-151. (Jan 2006).
• Burke G; Manson S; Figueiredo P; Davies N; Palace JA; Matthews PM. Effect of sildenafil citrate (Viagra) on cerebral blood flow in patients with multiple sclerosis. Clinical Neurosciences 2005 Meeting, 7 Sep 2005 - 9 Sep 2005. 77:130-130. B M J PUBLISHING GROUP (1 Jan 2006). Author weblink.
• Bhagwagar Z; Wylezinska M; Jezzard P; Evans J; Ashworth F; Sule A; Matthews PM; Cowen PJ. Cortical GABA levels and vulnerability to affective disorders. Summer Meeting of the British-Association-for-Psychoparmacology. 19:A6-A6. (Sep 2005).
• Pomeroy IM; Matthews PM; Frank J; Jordan EK; Esiri MM. Decreased neuronal density within cortical lesions in an animal model of multiple sclerosis. 21st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis/10th Annual Meeting of Rehabilitation in MS, 28 Sep 2005 - 1 Oct 2005. 11:S44-S44. HODDER ARNOLD, HODDER HEADLINE PLC (1 Sep 2005). Author weblink.
• Manson SC; Burke G; Voets N; Palace J; Matthews PM. Effect of sildenafil citrate on CBF and BOLD activation in multiple sclerosis patients. 21st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis/10th Annual Meeting of Rehabilitation in MS, 28 Sep 2005 - 1 Oct 2005. 11:S59-S59. HODDER ARNOLD, HODDER HEADLINE PLC (1 Sep 2005). Author weblink.
• Korteweg T; Tintore M; Uitdehaag BMJ; Rovira A; Montalban X; Miller DH; Fernando KTM; Filippi M; et alAgosta F; Fazekas F; Enzinger C; Matthews PM; Parry AMM; Polman CH; Barkhof F. MRI criteria for diagnosing MS in patients with a clinically isolated syndrome. 21st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis/10th Annual Meeting of Rehabilitation in MS, 28 Sep 2005 - 1 Oct 2005. 11:S22-S22. HODDER ARNOLD, HODDER HEADLINE PLC (1 Sep 2005). Author weblink.
• Burke G; Cavey A; Matthews PM; Palace JA. The evaluation of a novel "goat serum" therapy (Aimspro) in multiple sclerosis. Annual Meeting of the Association-of-British-Neurologists, 30 Mar 2005 - 1 Apr 2005. 76:1326-1326. B M J PUBLISHING GROUP (1 Sep 2005). Author weblink.
• Enzinger C; Fazekas F; Matthews PM; Ropele S; Schmidt H; Smith S; Schmidt R. Risk factors for progression of brain atrophy in aging - Six-year follow-up of normal subjects. 14th Meeting of the European-Neurological-Society. 64:1704-1711. (24 May 2005).
• Zarei M; Johansen-Berg J; Ramnani N; Matthews PM. In vivo mapping of cortical connections in the human internal capsule and its implication in functional recovery after stroke. Sino-British Joint Conference on Neurology, 15 Nov 2004 - 17 Nov 2004. 76:605-605. B M J PUBLISHING GROUP (1 Apr 2005). Author weblink.
• Devlin JT; Watkins KE; Sillery EL; Behrens TEJ; Johansen-Berg H; Nunes RG; Clare S; Matthews PM. Distinct fronto-temporal pathways mediate semantic and phonological processing. 12th Annnual Meeting of the Cognitive-Neuroscience-Society. 43-43. (2005).
• Wegner C; Esiri MM; Palace J; Matthews PM. Synaptic loss and impaired synaptic plasticity in cortical lesions of multiple sclerosis. Autumn Meeting of the Association-of-British-Neurologists. 76:152-152. (Jan 2005).
• Pomeroy IM; Esiri MM; Matthews PM; Palace J. Typical cortical lesions in an animal model of MS. Autumn Meeting of the Association-of-British-Neurologists, 22 Sep 2004 - 24 Sep 2004. 76:152-152. B M J PUBLISHING GROUP (1 Jan 2005). Author weblink.
• Abu-Omar Y; Cader MZ; Balacumaraswami L; Matthews PM; Taggart DP. Cerebral injury following on-pump and off-pump cardiac surgery defined by functional magnetic resonance imaging. 77th Scientific Meeting of the American-Heart-Association. 110:547-547. (26 Oct 2004).
• Cader MZ; Cifelli A; Abu-Omar Y; Palace J; Matthews PM. A verbal working memory task reveals new differences in the activation pattern of multiple sclerosis patients compared with healthy controls. 20th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple- Sclerosis/9th Annual Meeting of Rehabilitation in MS, 6 Oct 2004 - 9 Oct 2004. 10:S102-S103. ARNOLD, HODDER HEADLINE PLC (1 Sep 2004). Author weblink.
• Abu-Omar Y; Cifelli A; Matthews PM; Taggart DP. Cerebral injury following on pump and off pump cardiac surgery defined by functional MRI. Annual Conference of the British-Cardiac-Society. 90:A27-A27. (May 2004).
• Abu-Omar Y; Matthews PM; Cifelli A; Taggart DP. Defining cerebral dysfunction related to microembolism during cardiac surgery with functional magnetic resonance imaging. 76th Annual Scientific Session of the American-Heart-Association. 108:512-512. (28 Oct 2003).
• Abu-Omar Y; Balacumaraswami L; Pigott DW; Matthews PM; Taggart DP. Solid and gaseous cerebral microembolisation during off-pump, on-pump and open cardiac surgery. 76th Annual Scientific Session of the American-Heart-Association, 7 Nov 2003 - 12 Nov 2003. 108:549-549. LIPPINCOTT WILLIAMS & WILKINS (28 Oct 2003). Author weblink.
• Vollm BA; de Araujo IET; Kringelbach ML; Rolls ET; Cowen P; Matthews PM. Neural correlates of the subjective effects of i.v. amphetamine: an fMRI study in healthy volunteers. Summer Meeting of the British-Association-for-Psychopharmacology, 20 Jul 2003 - 23 Jul 2003. 17:A73-A73. SAGE PUBLICATIONS LTD (1 Sep 2003). Author weblink.
• Palace J; Parry A; Clare S; Jenkinson M; Smith S; Matthews PM. T1 changes detect the progression of pathology in the white matter and cortex of MS patients. Joint Congress of the Association-of-British-Neurologists/Neurological-Association-of-South-Africa. 74:1179-1179. (Aug 2003).
• Vollm BA; Araujo I; Kringelbach M; Rolls ET; Cowen PJ; Matthews PM. Neural correlates of the subjective effects of IV amphetamine: An fMRI study in healthy volunteers. 58th Annual Convention and Scientific Program of the Society-of-Biological-Psychiatry, 15 May 2003 - 17 May 2003. 53:216S-216S. ELSEVIER SCIENCE INC (15 Apr 2003). Author weblink.
• De Stefano N; Matthews PM; Filippi M; Agosta F; De Luca M; Bartolozzi ML; Guidi L; Ghezzi A; et alMontanari E; Cifelli A; Federico A; Smith SM. Evidence of early cortical atrophy in MS relevance to white matter changes and disability. 54th Annual Meeting of the American-Academy-of-Neurology, 13 Apr 2002 - 20 Apr 2002. 60:1157-1162. LIPPINCOTT WILLIAMS & WILKINS (8 Apr 2003). Author weblink.
• Robinson GV; Miall RC; Matthews PM; Jones EM; Winter J; Stein J; Stradling JR; Davies RJO. Brain fMRI activation and evoked potentials during visual stimulation and visuo-motor tracking in normal subjects before and after sleep deprivation. Winter Meeting of the British-Thoracic-Society. 57:U7-U7. (Dec 2002).
• De Stefano N; Narayanan S; Matthews PM; Mortilla M; Dotti MT; Federico A; Arnold DL. Proton MR spectroscopy to assess axonal damage in multiple sclerosis and other white matter disorders. Symposium on An Update on Multiple Sclerosis Research and Care, 3 May 1999 - 5 May 1999. 6:S121-S129. NATURE PUBLISHING GROUP (1 May 2000). Author weblink.
• Arnold DL; Wolinsky JS; Matthews PM; Falini A. The use of magnetic resonance spectroscopy in the evaluation of the natural history of multiple sclerosis. Meeting on the Magnetic Resonance Techniques in Multiple Sclerosis. 64:S94-S101. (May 1998).
• Matthews PM; Taivassalo T. Applications of magnetic resonance spectroscopy to diagnosis and monitoring of mitochondrial disease. Workshop on New MRI Techniques in Clinical Neurology, 17 Aug 1996. 18:341-351. SPRINGER VERLAG (1 Dec 1997). Author weblink DOI.
• MATTHEWS PM; FORD B; DANDURAND RJ; EIDELMAN DH; OCONNOR D; SHERWIN A; KARPATI G; ANDERMANN F; et alARNOLD DL. COENZYME-Q(10) WITH MULTIPLE VITAMINS IS GENERALLY INEFFECTIVE IN TREATMENT OF MITOCHONDRIAL DISEASE. 44th Annual Meeting of the American-Academy-of-Neurology, May 1992. 43:884-890. LIPPINCOTT-RAVEN PUBL (1 May 1993). Author weblink.